| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 6.43e-06 | 27 | 354 | 6 | GO:0023026 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 2.90e-05 | 11 | 354 | 4 | GO:0032395 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.35e-05 | 37 | 354 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 5.09e-05 | 38 | 354 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | integrin binding | ITGA1 ITGA4 ADAM8 ITGB4 ITGB8 PTK2 ANGPTL3 LTBP4 VCAM1 LAMB2 CASR TNR | 7.06e-05 | 175 | 354 | 12 | GO:0005178 |
| GeneOntologyMolecularFunction | MHC protein complex binding | 7.92e-05 | 41 | 354 | 6 | GO:0023023 | |
| GeneOntologyMolecularFunction | phospholipase activity | ALKBH5 PLA2G12A LIPG PLAAT2 ABHD16A PLCZ1 ENPP7 CASR PITPNM3 | 1.98e-04 | 114 | 354 | 9 | GO:0004620 |
| GeneOntologyMolecularFunction | peptide antigen binding | 2.19e-04 | 49 | 354 | 6 | GO:0042605 | |
| GeneOntologyMolecularFunction | estrogen binding | 3.13e-04 | 2 | 354 | 2 | GO:0099130 | |
| GeneOntologyMolecularFunction | 3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity | 3.13e-04 | 2 | 354 | 2 | GO:0004119 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | SLIT2 DMBT1 LTBP4 HSPG2 FRAS1 COL15A1 COL6A6 LAMB2 ZP1 MUC2 MUC5AC | 5.52e-04 | 188 | 354 | 11 | GO:0005201 |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 1.73e-07 | 16 | 355 | 6 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 1.73e-07 | 16 | 355 | 6 | GO:0002503 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB5 FCGR2B RAET1G ULBP2 RAET1L | 7.00e-07 | 76 | 355 | 10 | GO:0048002 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 9.80e-07 | 32 | 355 | 7 | GO:0019886 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 1.09e-06 | 21 | 355 | 6 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 1.09e-06 | 21 | 355 | 6 | GO:0002501 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 2.29e-06 | 36 | 355 | 7 | GO:0002495 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 3.36e-06 | 38 | 355 | 7 | GO:0002504 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ERBB2 HLA-DMA HLA-DOB ABCA12 HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB3 HLA-DRB5 ETS1 ITGA1 ITGA4 ADAM8 TNFRSF21 ITGB4 ITGB8 PTK2 PTK7 SLIT2 FAT1 NEGR1 AGER MAD1L1 TMEM131L UMOD PCDH10 VCAM1 PLXNB3 FLNA SDK2 NFKBIZ FNDC3A LRRC4B IL1RAPL1 CSK CD274 UBASH3B IL1RAP TNR IGSF21 | 4.13e-06 | 1077 | 355 | 40 | GO:0098609 |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 4.92e-06 | 56 | 355 | 8 | GO:0002418 | |
| GeneOntologyBiologicalProcess | positive regulation of response to tumor cell | 6.82e-06 | 28 | 355 | 6 | GO:0002836 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response to tumor cell | 6.82e-06 | 28 | 355 | 6 | GO:0002839 | |
| GeneOntologyBiologicalProcess | visceral serous pericardium development | 1.02e-05 | 9 | 355 | 4 | GO:0061032 | |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 1.07e-05 | 62 | 355 | 8 | GO:0050771 | |
| GeneOntologyBiologicalProcess | negative regulation of cell population proliferation | ERBB2 CEBPA TP53INP1 PSG6 INPP5D HLA-DRB1 INPPL1 ESR2 ETS1 ITGA1 TNFRSF21 SLIT2 PPARGC1A NFATC1 FCGR2B FKTN FZD5 AGER MAD1L1 KCNK2 TMEM131L UMOD VIPR2 HSPG2 ENPP7 RARRES1 ADAMTS1 WT1 NOX4 AR TGFBR3 CSK TNFRSF8 CD274 MUC2 TP53 | 1.07e-05 | 961 | 355 | 36 | GO:0008285 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 1.69e-05 | 48 | 355 | 7 | GO:0002478 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.95e-05 | 49 | 355 | 7 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | ERBB2 CEBPA HLA-DMA HLA-DOB HLA-DPB1 PSG6 INPP5D HLA-DRB1 HLA-DRB3 HLA-DRB5 ADAM8 TNFRSF21 TNFRSF4 FCGR2B AGER MAD1L1 TMEM131L ADGRF5 SHLD3 VCAM1 FLNA PARP3 RAET1G NFKBIZ CSK IGHD CD274 ULBP2 RAET1L UBASH3B | 2.08e-05 | 756 | 355 | 30 | GO:0050865 |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 2.23e-05 | 50 | 355 | 7 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | ERBB2 HLA-DMA HLA-DOB HLA-DPB1 PSG6 INPP5D HLA-DRB1 HLA-DRB3 HLA-DRB5 ADAM8 TNFRSF21 TNFRSF4 FCGR2B AGER MAD1L1 TMEM131L SHLD3 VCAM1 PARP3 RAET1G NFKBIZ CSK IGHD CD274 ULBP2 RAET1L | 2.54e-05 | 614 | 355 | 26 | GO:0051249 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | ERBB2 PDE3B HLA-DMA HLA-DOB ABCA12 HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB3 HLA-DRB5 ETS1 ITGA4 ADAM8 TNFRSF21 PTK2 AGER MAD1L1 TMEM131L KIF14 KNG1 VCAM1 PLXNB3 HSPG2 FLNA LAMB2 NFKBIZ SEMA5A FAF1 CSK PLXNC1 CD274 MACF1 UBASH3B TNR | 2.93e-05 | 927 | 355 | 34 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | ERBB2 CEBPA HLA-DMA HLA-DOB HLA-DPB1 PSG6 INPP5D HLA-DRB1 HLA-DRB3 HLA-DRB5 ADAM8 TNFRSF21 TNFRSF4 FCGR2B AGER MAD1L1 TMEM131L ADGRF5 SHLD3 VCAM1 PARP3 RAET1G NFKBIZ CSK IGHD CD274 ULBP2 RAET1L | 2.94e-05 | 694 | 355 | 28 | GO:0002694 |
| GeneOntologyBiologicalProcess | response to tumor cell | 2.95e-05 | 71 | 355 | 8 | GO:0002347 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB5 PSMB9 FCGR2B RAET1G ULBP2 RAET1L | 2.95e-05 | 139 | 355 | 11 | GO:0019882 |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | ERBB2 PDE3B ABCA12 PSG6 HLA-DRB1 ADAM8 TNFRSF21 PTK2 AGER MAD1L1 TMEM131L KNG1 PLXNB3 HSPG2 SEMA5A PLXNC1 CD274 UBASH3B TNR | 3.01e-05 | 375 | 355 | 19 | GO:0007162 |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | CEBPA HLA-DMA HLA-DOB HLA-DPB1 INPP5D HLA-DRB1 HLA-DRB3 HLA-DRB5 ADAM8 TNFRSF4 AGER SHLD3 VCAM1 FLNA RAET1G NFKBIZ CSK IGHD CD274 ULBP2 RAET1L | 3.76e-05 | 449 | 355 | 21 | GO:0050867 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | HLA-DMA HLA-DOB HLA-DPB1 INPP5D HLA-DRB1 HLA-DRB3 HLA-DRB5 ADAM8 TNFRSF4 AGER SHLD3 VCAM1 RAET1G NFKBIZ CSK IGHD CD274 ULBP2 RAET1L | 4.30e-05 | 385 | 355 | 19 | GO:0051251 |
| GeneOntologyBiologicalProcess | negative regulation of axon extension | 4.32e-05 | 38 | 355 | 6 | GO:0030517 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | ERBB2 CEBPA PSG6 INPP5D MCF2 SEMA3G TTC3 PTK2 SLIT2 FCGR2B TMEM131L TRPV1 HDAC6 SEMA5A THOC5 UBASH3B TNR TP53 | 4.48e-05 | 353 | 355 | 18 | GO:0010721 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | CEBPA HLA-DMA HLA-DOB HLA-DPB1 INPP5D HLA-DRB1 HLA-DRB3 HLA-DRB5 ADAM8 TNFRSF4 AGER SHLD3 VCAM1 RAET1G NFKBIZ CSK IGHD CD274 ULBP2 RAET1L | 4.94e-05 | 423 | 355 | 20 | GO:0002696 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | ITGA1 ITGA4 ERBIN ITGB4 ITGB8 PTK2 ANGPTL3 FLNA ADAMTS1 LAMB2 | 5.77e-05 | 124 | 355 | 10 | GO:0007229 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 5.96e-05 | 58 | 355 | 7 | GO:0019884 | |
| GeneOntologyBiologicalProcess | cell activation | SCN11A ERBB2 CEBPA HLA-DMA HLA-DOB HLA-DPB1 PSG6 INPP5D HLA-DRB1 HLA-DRB3 HLA-DRB5 ITGA4 ADAM8 TNFRSF21 ALKBH5 ITGB8 TNFRSF4 NFATC1 FCGR2B FZD5 AGER PRMT5 MAD1L1 TMEM131L ADGRF5 HECTD1 SHLD3 VCAM1 FLNA PLCZ1 TRPV1 PARP3 RAET1G NFKBIZ ZP1 CSK IGHD CD274 ULBP2 RAET1L UBASH3B TRBC2 TP53 | 8.00e-05 | 1356 | 355 | 43 | GO:0001775 |
| GeneOntologyBiologicalProcess | pericardium development | 1.04e-04 | 28 | 355 | 5 | GO:0060039 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | RASGRP4 HLA-DMA PSG6 INPP5D HLA-DRB1 HLA-DRB3 RNF19B FCGR2B FZD5 AGER SHLD3 TRB PARP3 RAET1G NFKBIZ FCGR2C IGHD CD274 ULBP2 RAET1L | 1.12e-04 | 449 | 355 | 20 | GO:0002449 |
| GeneOntologyBiologicalProcess | T cell mediated immunity | HLA-DRB1 HLA-DRB3 FCGR2B FZD5 AGER TRB RAET1G NFKBIZ CD274 ULBP2 RAET1L | 1.26e-04 | 163 | 355 | 11 | GO:0002456 |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | HLA-DRB1 HLA-DRB3 FCGR2B FZD5 AGER RAET1G CD274 ULBP2 RAET1L | 1.30e-04 | 111 | 355 | 9 | GO:0002709 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | MCF2 SEMA3G TTC3 PTK2 SLIT2 KEL PLXNB3 HDAC6 SEMA5A PLXNC1 MACF1 TNR | 1.30e-04 | 192 | 355 | 12 | GO:0050770 |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | ERBB2 PDE3B PDE4B CEBPA PSG6 INPP5D HLA-DRB1 ESR2 ADGRB2 MCF2 SEMA3G ITGA4 TTC3 ERBIN TNFRSF21 PTK2 TNFRSF4 APOM SLIT2 FCGR2B AGER MAD1L1 KCNK2 TMEM131L ADGRF5 KNG1 HSPG2 TRPV1 HDAC6 ADAMTS1 PARP3 WT1 SEMA5A THOC5 ZFPM2 TGFBR3 ZNF750 CSK TRIM62 CD274 LTBP3 UBASH3B AKAP1 TNR TP53 | 1.61e-04 | 1488 | 355 | 45 | GO:0051241 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | SCN11A PDE3A PDE3B PSG6 VPS13C INPPL1 INSIG1 DBH ITGA4 ERBIN ADCY8 PTK2 ITPR3 SLIT2 FAT1 FCGR2B AGER PRMT5 UMOD KCNQ3 VCAM1 FLNA TRPV1 HDAC6 RAET1G DUOX2 NFKBIZ CASR OGG1 FAF1 TGFBR3 ZNF106 TH SETD2 CSK ULBP2 RAET1L TP53 HTT ZC3HAV1 | 1.72e-04 | 1272 | 355 | 40 | GO:1901698 |
| GeneOntologyBiologicalProcess | T cell mediated immune response to tumor cell | 1.72e-04 | 17 | 355 | 4 | GO:0002424 | |
| GeneOntologyBiologicalProcess | leukocyte activation | SCN11A ERBB2 CEBPA HLA-DMA HLA-DOB HLA-DPB1 PSG6 INPP5D HLA-DRB1 HLA-DRB3 HLA-DRB5 ITGA4 ADAM8 TNFRSF21 ALKBH5 ITGB8 TNFRSF4 NFATC1 FCGR2B FZD5 AGER MAD1L1 TMEM131L ADGRF5 HECTD1 SHLD3 VCAM1 TRPV1 PARP3 RAET1G NFKBIZ CSK IGHD CD274 ULBP2 RAET1L TRBC2 TP53 | 1.73e-04 | 1186 | 355 | 38 | GO:0045321 |
| GeneOntologyBiologicalProcess | lymphocyte activation | ERBB2 HLA-DMA HLA-DOB HLA-DPB1 PSG6 INPP5D HLA-DRB1 HLA-DRB3 HLA-DRB5 ITGA4 ADAM8 TNFRSF21 ALKBH5 TNFRSF4 NFATC1 FCGR2B FZD5 AGER MAD1L1 TMEM131L HECTD1 SHLD3 VCAM1 PARP3 RAET1G NFKBIZ CSK IGHD CD274 ULBP2 RAET1L TRBC2 TP53 | 1.80e-04 | 976 | 355 | 33 | GO:0046649 |
| GeneOntologyBiologicalProcess | tissue remodeling | PSG6 INPP5D DBH ITGA4 ADAM8 SIGLEC15 UMOD FLNA NOX4 TGFBR3 CSK LTBP3 UBASH3B TP53 | 1.93e-04 | 262 | 355 | 14 | GO:0048771 |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | ERBB2 HLA-DMA HLA-DOB ABCA12 HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB3 HLA-DRB5 ETS1 ITGA4 ADAM8 TNFRSF21 PTK2 AGER MAD1L1 TMEM131L VCAM1 NFKBIZ CSK CD274 UBASH3B TNR | 1.96e-04 | 580 | 355 | 23 | GO:0022407 |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 1.99e-04 | 70 | 355 | 7 | GO:0001913 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.99e-04 | 70 | 355 | 7 | GO:0045124 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | RASGRP4 PSG6 HLA-DRB1 HLA-DRB3 FCGR2B FZD5 AGER SHLD3 PARP3 RAET1G CD274 ULBP2 RAET1L | 2.04e-04 | 232 | 355 | 13 | GO:0002706 |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | HLA-DMA HLA-DRB1 HLA-DRB3 FCGR2B FZD5 AGER SHLD3 PARP3 RAET1G NFKBIZ CD274 ULBP2 RAET1L | 2.32e-04 | 235 | 355 | 13 | GO:0002822 |
| GeneOntologyBiologicalProcess | embryonic placenta morphogenesis | 2.34e-04 | 33 | 355 | 5 | GO:0060669 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 2.60e-04 | 52 | 355 | 6 | GO:0071526 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | PDE3A PDE3B PSG6 INPPL1 INSIG1 ITGA4 ADCY8 PTK2 ITPR3 SLIT2 FAT1 FCGR2B AGER PRMT5 KCNQ3 VCAM1 FLNA TRPV1 RAET1G ZNF106 TH CSK ULBP2 RAET1L TP53 HTT ZC3HAV1 | 2.77e-04 | 752 | 355 | 27 | GO:1901699 |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | HLA-DMA HLA-DRB1 HLA-DRB3 FZD5 SHLD3 RAET1G NFKBIZ CD274 ULBP2 RAET1L | 2.79e-04 | 150 | 355 | 10 | GO:0002824 |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 2.89e-04 | 53 | 355 | 6 | GO:0001914 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | INPP5D INPPL1 PLPPR3 LPCAT2 PLA2G12A LIPG PGAP2 ANGPTL3 PLAAT2 ADGRF5 PIPSL ABHD16A ENPP7 PIGQ MTMR7 SOCS4 PITPNM3 SERINC5 | 2.91e-04 | 410 | 355 | 18 | GO:0006644 |
| GeneOntologyBiologicalProcess | epinephrine biosynthetic process | 2.95e-04 | 2 | 355 | 2 | GO:0042418 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion in response to extracellular stimulus | 2.95e-04 | 2 | 355 | 2 | GO:0140039 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | ERBB2 HLA-DMA HLA-DOB HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB3 HLA-DRB5 ETS1 ITGA4 ADAM8 TNFRSF21 AGER MAD1L1 TMEM131L VCAM1 NFKBIZ CSK CD274 | 2.98e-04 | 447 | 355 | 19 | GO:1903037 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | ERBB2 PSG6 INPP5D HLA-DRB1 TNFRSF21 FCGR2B MAD1L1 TMEM131L CD274 | 2.99e-04 | 124 | 355 | 9 | GO:0050672 |
| GeneOntologyBiologicalProcess | bone resorption | 3.12e-04 | 99 | 355 | 8 | GO:0045453 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ETS1 ADAM8 PTK2 ZNF469 PHLDB1 FKTN LOXL4 LTBP4 HSPG2 COL15A1 ADAMTS1 WT1 LAMB2 SEMA5A TGFBR3 ADAMTS6 TNR | 3.14e-04 | 377 | 355 | 17 | GO:0030198 |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | ERBB2 HLA-DMA HLA-DOB HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB3 HLA-DRB5 ETS1 ITGA4 ADAM8 TNFRSF21 AGER MAD1L1 TMEM131L UMOD VCAM1 NFKBIZ CSK CD274 | 3.16e-04 | 486 | 355 | 20 | GO:0007159 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ETS1 ADAM8 PTK2 ZNF469 PHLDB1 FKTN LOXL4 LTBP4 HSPG2 COL15A1 ADAMTS1 WT1 LAMB2 SEMA5A TGFBR3 ADAMTS6 TNR | 3.23e-04 | 378 | 355 | 17 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ETS1 ADAM8 PTK2 ZNF469 PHLDB1 FKTN LOXL4 LTBP4 HSPG2 COL15A1 ADAMTS1 WT1 LAMB2 SEMA5A TGFBR3 ADAMTS6 TNR | 3.33e-04 | 379 | 355 | 17 | GO:0045229 |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | ERBB2 PSG6 INPP5D HLA-DRB1 TNFRSF21 FCGR2B MAD1L1 TMEM131L CD274 | 3.37e-04 | 126 | 355 | 9 | GO:0032945 |
| GeneOntologyBiologicalProcess | susceptibility to natural killer cell mediated cytotoxicity | 3.93e-04 | 9 | 355 | 3 | GO:0042271 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SCN11A ERBB2 MYO9A MCF2 ITGA1 SEMA3G ITGA4 TTC3 ADAM8 PTK2 PTK7 SLIT2 PRDM8 FAT1 NEGR1 KEL PLXNB3 CAP1 HSPG2 FLNA HDAC6 LAMB2 NOX4 SEMA5A FRYL SHROOM2 ECT2 AR ACTR2 THOC5 STRIP1 IL1RAPL1 PLXNC1 KLK8 MACF1 TNR PHACTR1 | 4.02e-04 | 1194 | 355 | 37 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | HLA-DMA HLA-DRB1 HLA-DRB3 FZD5 SHLD3 RAET1G NFKBIZ CD274 ULBP2 RAET1L | 4.44e-04 | 159 | 355 | 10 | GO:0002821 |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | RASGRP4 SCN11A HLA-DMA PSG6 INPP5D HLA-DRB1 HLA-DRB3 RNF19B DBH FCGR2B FZD5 AGER SHLD3 TRB PARP3 RAET1G NFKBIZ FCGR2C IGHD CD274 ULBP2 RAET1L | 4.47e-04 | 576 | 355 | 22 | GO:0002443 |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | HLA-DMA HLA-DRB1 HLA-DRB3 FCGR2B FZD5 AGER SHLD3 PARP3 RAET1G NFKBIZ CD274 ULBP2 RAET1L | 4.53e-04 | 252 | 355 | 13 | GO:0002819 |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 4.56e-04 | 80 | 355 | 7 | GO:0046850 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 4.90e-04 | 161 | 355 | 10 | GO:0051592 | |
| GeneOntologyBiologicalProcess | cellular response to exogenous dsRNA | 4.94e-04 | 22 | 355 | 4 | GO:0071360 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | INCENP INPPL1 MCF2 SEMA3G WDR54 TTC3 PTK2 APOM PHF2 SLIT2 PPARGC1A FCGR2B SACS MAD1L1 KIF14 PLXNB3 HSPG2 FLNA HDAC6 SEMA5A HUWE1 SHROOM2 AR TGFBR3 NANOS2 CSK KANK4 TNR TP53 | 4.99e-04 | 864 | 355 | 29 | GO:0051129 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | ERBB2 PSG6 INPP5D HLA-DRB1 TNFRSF21 FCGR2B MAD1L1 TMEM131L CD274 | 5.30e-04 | 134 | 355 | 9 | GO:0070664 |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | ERBB2 HLA-DPB1 PSG6 INPP5D HLA-DRB1 TNFRSF21 ALKBH5 TNFRSF4 FCGR2B AGER MAD1L1 TMEM131L VCAM1 NFKBIZ IGHD CD274 TP53 | 5.81e-04 | 398 | 355 | 17 | GO:0046651 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | ERBB2 PDE3B AHI1 HLA-DMA MYO9A PSG6 ADGRB2 ETS1 MCF2 SEMA3G TTC3 ITGB8 PTK2 PTK7 SLIT2 PPARGC1A PHLDB1 ANGPTL3 KEL PLXNB3 HSPG2 HDAC6 ADAMTS1 WT1 SEMA5A HUWE1 AR ACTR2 STRIP1 IL1RAPL1 INF2 PLXNC1 MACF1 TNR | 6.18e-04 | 1090 | 355 | 34 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of cell development | ERBB2 PDE3A CEBPA HLA-DMA PSG6 INPP5D HLA-DRB1 ETS1 MCF2 SEMA3G TTC3 ADAM8 SIGLEC15 PTK2 SLIT2 FCGR2B AGER PRMT5 TMEM131L KIF14 PLXNB3 TRPV1 HDAC6 NFKBIZ SEMA5A ACTR2 THOC5 IL1RAPL1 PLXNC1 MACF1 AKAP11 UBASH3B TNR TP53 | 6.70e-04 | 1095 | 355 | 34 | GO:0060284 |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | ERBB2 HLA-DPB1 PSG6 INPP5D HLA-DRB1 TNFRSF21 PTK2 TNFRSF4 FCGR2B AGER MAD1L1 TMEM131L VCAM1 IGHD CD274 | 6.84e-04 | 332 | 355 | 15 | GO:0070663 |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 6.90e-04 | 139 | 355 | 9 | GO:0007173 | |
| GeneOntologyBiologicalProcess | type II interferon production | PDE4B HLA-DPB1 HLA-DRB1 RNF19B FZD5 RAET1G NFKBIZ CD274 ULBP2 RAET1L | 7.16e-04 | 169 | 355 | 10 | GO:0032609 |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 7.16e-04 | 169 | 355 | 10 | GO:0010977 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | ERBB2 HLA-DPB1 PSG6 INPP5D HLA-DRB1 TNFRSF21 ALKBH5 TNFRSF4 FCGR2B AGER MAD1L1 TMEM131L VCAM1 NFKBIZ IGHD CD274 TP53 | 7.24e-04 | 406 | 355 | 17 | GO:0032943 |
| GeneOntologyBiologicalProcess | regulation of mRNA export from nucleus | 7.53e-04 | 11 | 355 | 3 | GO:0010793 | |
| GeneOntologyBiologicalProcess | micturition | 7.53e-04 | 11 | 355 | 3 | GO:0060073 | |
| GeneOntologyBiologicalProcess | leukocyte proliferation | ERBB2 HLA-DPB1 PSG6 INPP5D HLA-DRB1 TNFRSF21 ALKBH5 PTK2 TNFRSF4 FCGR2B AGER MAD1L1 TMEM131L VCAM1 NFKBIZ IGHD CD274 TP53 | 7.61e-04 | 445 | 355 | 18 | GO:0070661 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte proliferation | ERBB2 HLA-DPB1 PSG6 INPP5D HLA-DRB1 TNFRSF21 TNFRSF4 FCGR2B AGER MAD1L1 TMEM131L VCAM1 IGHD CD274 | 7.73e-04 | 301 | 355 | 14 | GO:0050670 |
| GeneOntologyBiologicalProcess | mesenchyme development | SEMA3G ITGA4 ADAM8 PTK2 PTK7 PHLDB1 NFATC1 AGER FLNA WT1 SEMA5A ZFPM2 TGFBR3 ZNF750 TRIM62 HTT | 7.77e-04 | 372 | 355 | 16 | GO:0060485 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 8.20e-04 | 25 | 355 | 4 | GO:0002483 | |
| GeneOntologyBiologicalProcess | epithelial cell development | CEBPA ABCA12 ESR2 FAT1 FZD5 FLNA WT1 LAMB2 FNDC3A AR AKAP11 ROS1 MUC2 | 8.32e-04 | 269 | 355 | 13 | GO:0002064 |
| GeneOntologyBiologicalProcess | synapse organization | ERBB2 MYO9A ADGRB2 PTK2 PTK7 SLIT2 FCGR2B NEGR1 FZD5 VSTM5 CAP1 FLNA SDK2 HDAC6 LAMB2 LRRC4B NBEA ACTR2 IL1RAPL1 PLXNC1 KLK8 IL1RAP TNR IGSF21 | 8.45e-04 | 685 | 355 | 24 | GO:0050808 |
| GeneOntologyBiologicalProcess | negative regulation of female gonad development | 8.76e-04 | 3 | 355 | 2 | GO:2000195 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell antigen processing and presentation | 8.76e-04 | 3 | 355 | 2 | GO:0002469 | |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell proliferation | ERBB2 HLA-DPB1 PSG6 INPP5D HLA-DRB1 TNFRSF21 TNFRSF4 FCGR2B AGER MAD1L1 TMEM131L VCAM1 IGHD CD274 | 9.07e-04 | 306 | 355 | 14 | GO:0032944 |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-10 production | 9.56e-04 | 26 | 355 | 4 | GO:0032693 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 9.90e-04 | 91 | 355 | 7 | GO:0033627 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 2.60e-07 | 17 | 359 | 6 | GO:0042613 | |
| GeneOntologyCellularComponent | cell surface | HLA-DMA HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB5 ITGA1 ITGA4 ADAM8 PTGFRN ITGB4 ITGB8 TNFRSF4 SLIT2 FCGR2B LIPG FZD5 AGER KCNK2 ANGPTL3 UMOD KCNQ3 ADGRF5 VCAM1 PLXNB3 TRPV1 MXRA8 RAET1G DUOX2 CASR CUBN IL1RAPL1 MST1R TGFBR3 FCGR2C IGHD CD274 ULBP2 RAET1L ROS1 TNR IGSF21 | 3.47e-06 | 1111 | 359 | 41 | GO:0009986 |
| GeneOntologyCellularComponent | MHC protein complex | 4.24e-06 | 26 | 359 | 6 | GO:0042611 | |
| GeneOntologyCellularComponent | actin cytoskeleton | HIP1 MYLK MYO9A INPP5D ADAM8 ADCY8 PTK2 ACTL8 GNG12 VCAM1 CAP1 FLNA FLNC CDC42BPA NOX4 SHROOM2 ACTR2 EEF1A1 MST1R AFAP1 LLGL2 INF2 CD274 MACF1 PPP1R12C | 2.35e-05 | 576 | 359 | 25 | GO:0015629 |
| GeneOntologyCellularComponent | plasma membrane protein complex | SCN11A ERBB2 PDE4B HLA-DMA HLA-DOB HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB3 HLA-DRB5 ITGA1 ITGA4 ADAM8 ITGB4 ITGB8 GNG12 KCNK2 KCNQ3 VCAM1 HSPG2 FLNA TRB DUOX2 NOX4 FAF1 TGFBR3 IGHD TRBC2 | 2.31e-04 | 785 | 359 | 28 | GO:0098797 |
| GeneOntologyCellularComponent | side of membrane | RASGRP4 HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB3 HLA-DRB5 ITGA1 ITGA4 TNFRSF4 ITPR3 GNG12 FCGR2B NEGR1 DPEP3 UMOD VCAM1 TRPV1 RAET1G CUBN ALG2 EEF1A1 EEF1A2 TGFBR3 TH FCGR2C IGHD CD274 ULBP2 RAET1L IGSF21 | 2.72e-04 | 875 | 359 | 30 | GO:0098552 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 5.15e-04 | 59 | 359 | 6 | GO:0098636 | |
| GeneOntologyCellularComponent | cell cortex | HIP1 INPP5D ITGB4 PTK2 PHLDB1 EXOC3L4 CAP1 PDZD4 FLNA FRYL SHROOM2 ECT2 ACTR2 EEF1A1 LLGL2 MACF1 | 7.39e-04 | 371 | 359 | 16 | GO:0005938 |
| GeneOntologyCellularComponent | mucus layer | 8.72e-04 | 3 | 359 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | actomyosin | 9.41e-04 | 117 | 359 | 8 | GO:0042641 | |
| GeneOntologyCellularComponent | nuclear body | MAGEA1 TPP2 MAGEA8 TP53INP1 INCENP CENPC INPPL1 ZMYM2 ERBIN ALKBH5 PTK2 PPARGC1A PRDM8 NFATC1 HECTD1 PARP3 WRN WT1 NFKBIZ ECT2 OGG1 AR ZNF106 BABAM1 GCAT PRPF4 REXO1L1P TP53 RNF111 | 9.67e-04 | 903 | 359 | 29 | GO:0016604 |
| GeneOntologyCellularComponent | actin filament bundle | 9.94e-04 | 118 | 359 | 8 | GO:0032432 | |
| GeneOntologyCellularComponent | receptor complex | ERBB2 PSG6 GPR63 ITGA1 ITGA4 ITGB4 ITGB8 ITPR3 AHRR LOXL4 PLXNB3 FLNA TRB CUBN MST1R TGFBR3 IGHD PLXNC1 TAS1R2 ROS1 TRBC2 | 1.17e-03 | 581 | 359 | 21 | GO:0043235 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.26e-03 | 13 | 359 | 3 | GO:0002116 | |
| Domain | Ig-like_fold | IGSF8 MYLK VSIG2 HLA-DMA HLA-DOB HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB3 HLA-DRB5 SEMA3G PTGFRN ITGB4 SIGLEC15 PTK7 IL22RA2 NFATC1 FCGR2B NEGR1 AGER ADGRF5 VSTM5 IGLON5 VCAM1 PLXNB3 HSPG2 FLNA FLNC SDK2 TRB MXRA8 FNDC3A LRRC4B IL1RAPL1 MST1R IGHD PLXNC1 CD274 ROS1 IL1RAP TNR IGSF21 FCAMR LRIT1 | 1.71e-12 | 706 | 346 | 44 | IPR013783 |
| Domain | - | IGSF8 MYLK VSIG2 HLA-DOB HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB3 HLA-DRB5 SEMA3G PTGFRN ITGB4 SIGLEC15 PTK7 IL22RA2 NFATC1 FCGR2B NEGR1 AGER ADGRF5 VSTM5 IGLON5 VCAM1 PLXNB3 HSPG2 FLNA FLNC SDK2 MXRA8 FNDC3A LRRC4B IL1RAPL1 MST1R PLXNC1 CD274 ROS1 IL1RAP TNR IGSF21 FCAMR LRIT1 | 1.34e-11 | 663 | 346 | 41 | 2.60.40.10 |
| Domain | Ig-like_dom | IGSF8 MYLK VSIG2 HLA-DMA HLA-DOB HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB3 HLA-DRB5 SEMA3G PTGFRN SIGLEC15 PTK7 FCGR2B NEGR1 AGER ADGRF5 VSTM5 IGLON5 VCAM1 HSPG2 SDK2 TRB MXRA8 LRRC4B IL1RAPL1 IGHD CD274 IL1RAP IGSF21 FCAMR LRIT1 | 3.39e-10 | 503 | 346 | 33 | IPR007110 |
| Domain | IG_LIKE | IGSF8 MYLK VSIG2 HLA-DMA HLA-DOB HLA-DPB1 PSG6 HLA-DRB1 HLA-DRB3 HLA-DRB5 SEMA3G PTGFRN SIGLEC15 PTK7 FCGR2B NEGR1 AGER ADGRF5 IGLON5 VCAM1 HSPG2 SDK2 TRB MXRA8 LRRC4B IL1RAPL1 IGHD CD274 IL1RAP IGSF21 FCAMR LRIT1 | 7.51e-10 | 491 | 346 | 32 | PS50835 |
| Domain | IG_MHC | VSIG2 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB5 AGER RAET1G IGHD ULBP2 RAET1L | 8.51e-10 | 60 | 346 | 12 | PS00290 |
| Domain | IG | IGSF8 MYLK VSIG2 PSG6 SEMA3G PTGFRN SIGLEC15 PTK7 FCGR2B NEGR1 AGER ADGRF5 VSTM5 IGLON5 VCAM1 HSPG2 SDK2 TRB MXRA8 LRRC4B IL1RAPL1 CD274 IL1RAP IGSF21 FCAMR LRIT1 | 9.18e-08 | 421 | 346 | 26 | SM00409 |
| Domain | Ig_sub | IGSF8 MYLK VSIG2 PSG6 SEMA3G PTGFRN SIGLEC15 PTK7 FCGR2B NEGR1 AGER ADGRF5 VSTM5 IGLON5 VCAM1 HSPG2 SDK2 TRB MXRA8 LRRC4B IL1RAPL1 CD274 IL1RAP IGSF21 FCAMR LRIT1 | 9.18e-08 | 421 | 346 | 26 | IPR003599 |
| Domain | Ig/MHC_CS | HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB5 AGER RAET1G IGHD ULBP2 | 9.91e-08 | 58 | 346 | 10 | IPR003006 |
| Domain | MHC_II_b_N | 1.13e-07 | 8 | 346 | 5 | PD000328 | |
| Domain | MHC_II_beta | 2.51e-07 | 9 | 346 | 5 | SM00921 | |
| Domain | MHC_II_b_N | 2.51e-07 | 9 | 346 | 5 | IPR000353 | |
| Domain | MHC_II_beta | 2.51e-07 | 9 | 346 | 5 | PF00969 | |
| Domain | MHC_I/II-like_Ag-recog | HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB5 RAET1G ULBP2 RAET1L | 3.85e-07 | 38 | 346 | 8 | IPR011162 |
| Domain | ig | HLA-DMA PSG6 SEMA3G PTGFRN FCGR2B NEGR1 AGER ADGRF5 IGLON5 VCAM1 HSPG2 SDK2 IL1RAPL1 IGHD IGSF21 LRIT1 | 5.31e-07 | 190 | 346 | 16 | PF00047 |
| Domain | Immunoglobulin | HLA-DMA PSG6 SEMA3G PTGFRN FCGR2B NEGR1 AGER ADGRF5 IGLON5 VCAM1 HSPG2 SDK2 IL1RAPL1 IGHD IGSF21 LRIT1 | 5.31e-07 | 190 | 346 | 16 | IPR013151 |
| Domain | MHC_II_a/b_N | 3.70e-06 | 14 | 346 | 5 | IPR014745 | |
| Domain | - | 3.70e-06 | 14 | 346 | 5 | 3.10.320.10 | |
| Domain | V-set | IGSF8 VSIG2 PSG6 PTGFRN SIGLEC15 VSTM5 IGLON5 VCAM1 HSPG2 TRB MXRA8 CD274 IGSF21 FCAMR | 8.90e-06 | 184 | 346 | 14 | PF07686 |
| Domain | PSI | 1.50e-05 | 44 | 346 | 7 | IPR016201 | |
| Domain | PSI | 2.03e-05 | 46 | 346 | 7 | SM00423 | |
| Domain | Ig_V-set | IGSF8 VSIG2 PSG6 PTGFRN SIGLEC15 VSTM5 IGLON5 VCAM1 HSPG2 TRB MXRA8 CD274 IGSF21 FCAMR | 2.16e-05 | 199 | 346 | 14 | IPR013106 |
| Domain | ZP_dom_CS | 2.23e-05 | 10 | 346 | 4 | IPR017977 | |
| Domain | IGc2 | MYLK VSIG2 PSG6 PTK7 FCGR2B NEGR1 AGER ADGRF5 IGLON5 VCAM1 HSPG2 SDK2 LRRC4B IL1RAPL1 LRIT1 | 3.46e-05 | 235 | 346 | 15 | SM00408 |
| Domain | Ig_sub2 | MYLK VSIG2 PSG6 PTK7 FCGR2B NEGR1 AGER ADGRF5 IGLON5 VCAM1 HSPG2 SDK2 LRRC4B IL1RAPL1 LRIT1 | 3.46e-05 | 235 | 346 | 15 | IPR003598 |
| Domain | Ig_I-set | MYLK VSIG2 PTK7 NEGR1 AGER ADGRF5 IGLON5 VCAM1 HSPG2 SDK2 LRRC4B IL1RAPL1 LRIT1 | 5.65e-05 | 190 | 346 | 13 | IPR013098 |
| Domain | I-set | MYLK VSIG2 PTK7 NEGR1 AGER ADGRF5 IGLON5 VCAM1 HSPG2 SDK2 LRRC4B IL1RAPL1 LRIT1 | 5.65e-05 | 190 | 346 | 13 | PF07679 |
| Domain | IGc1 | 7.49e-05 | 56 | 346 | 7 | SM00407 | |
| Domain | Ig_C1-set | 9.41e-05 | 58 | 346 | 7 | IPR003597 | |
| Domain | ZP_2 | 1.00e-04 | 14 | 346 | 4 | PS51034 | |
| Domain | ZP_1 | 1.00e-04 | 14 | 346 | 4 | PS00682 | |
| Domain | ZP | 1.34e-04 | 15 | 346 | 4 | SM00241 | |
| Domain | ZP_dom | 2.28e-04 | 17 | 346 | 4 | IPR001507 | |
| Domain | Zona_pellucida | 2.28e-04 | 17 | 346 | 4 | PF00100 | |
| Domain | SEMA | 2.42e-04 | 31 | 346 | 5 | PS51004 | |
| Domain | Semap_dom | 2.42e-04 | 31 | 346 | 5 | IPR001627 | |
| Domain | Sema | 2.42e-04 | 31 | 346 | 5 | SM00630 | |
| Domain | Sema | 2.42e-04 | 31 | 346 | 5 | PF01403 | |
| Domain | Plexin_repeat | 2.83e-04 | 32 | 346 | 5 | IPR002165 | |
| Domain | PSI | 2.83e-04 | 32 | 346 | 5 | PF01437 | |
| Domain | Transl_elong_EF1A_euk/arc | 3.42e-04 | 2 | 346 | 2 | IPR004539 | |
| Domain | C1-set | 4.73e-04 | 54 | 346 | 6 | PF07654 | |
| Domain | GST_N_3 | 4.87e-04 | 9 | 346 | 3 | PF13417 | |
| Domain | VWF_A | 5.07e-04 | 99 | 346 | 8 | IPR002035 | |
| Domain | VWFA | 8.15e-04 | 82 | 346 | 7 | PS50234 | |
| Domain | VWA | 9.41e-04 | 84 | 346 | 7 | SM00327 | |
| Domain | EGF-like_CS | ZNRF4 ADAM8 ITGB4 ITGB8 SLIT2 FAT1 UMOD LTBP4 HSPG2 LAMB2 CUBN LTBP3 TNR | 1.22e-03 | 261 | 346 | 13 | IPR013032 |
| Domain | WWE | 1.22e-03 | 12 | 346 | 3 | PF02825 | |
| Domain | WWE-dom | 1.22e-03 | 12 | 346 | 3 | IPR004170 | |
| Domain | WWE | 1.22e-03 | 12 | 346 | 3 | PS50918 | |
| Domain | Tyr_kinase_cat_dom | 1.24e-03 | 88 | 346 | 7 | IPR020635 | |
| Domain | TyrKc | 1.24e-03 | 88 | 346 | 7 | SM00219 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 1.81e-07 | 15 | 265 | 6 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 1.81e-07 | 15 | 265 | 6 | M47604 | |
| Pathway | REACTOME_PD_1_SIGNALING | 1.11e-05 | 28 | 265 | 6 | M18810 | |
| Pathway | KEGG_ASTHMA | 1.69e-05 | 30 | 265 | 6 | M13950 | |
| Pathway | KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION | 2.92e-05 | 48 | 265 | 7 | M615 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB5 ITGA4 ITGB8 NEGR1 VCAM1 CD274 | 4.19e-05 | 133 | 265 | 11 | M16476 |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 5.76e-05 | 23 | 265 | 5 | M47720 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB5 ITGA4 FCGR2C | 5.93e-05 | 72 | 265 | 8 | M3126 |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 5.94e-05 | 37 | 265 | 6 | M18615 | |
| Pathway | BIOCARTA_MHC_PATHWAY | 1.05e-04 | 14 | 265 | 4 | M22023 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 1.05e-04 | 14 | 265 | 4 | M1473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 1.08e-04 | 26 | 265 | 5 | M47719 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 1.08e-04 | 41 | 265 | 6 | M13519 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 1.42e-04 | 43 | 265 | 6 | M12617 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.78e-04 | 84 | 265 | 8 | M7098 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ITGA1 ITGA4 ADAM8 ITGB4 ITGB8 LOXL4 LTBP4 VCAM1 HSPG2 COL15A1 COL6A6 ADAMTS1 LAMB2 CAPN7 LTBP3 TNR | 1.81e-04 | 300 | 265 | 16 | M610 |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 2.19e-04 | 30 | 265 | 5 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 2.19e-04 | 30 | 265 | 5 | M47718 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.32e-04 | 66 | 265 | 7 | MM15925 | |
| Pathway | REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 2.40e-04 | 17 | 265 | 4 | MM14829 | |
| Pathway | REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 3.03e-04 | 18 | 265 | 4 | M27118 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 3.79e-04 | 19 | 265 | 4 | M10959 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | PSG6 ITGA1 ITGA4 ADAM8 ITGB4 ITGB8 LOXL4 LTBP4 VCAM1 COL15A1 COL6A6 CAPN7 LTBP3 TNR | 3.83e-04 | 258 | 265 | 14 | MM14572 |
| Pathway | WP_FOCAL_ADHESION | ERBB2 MYLK ITGA1 ITGA4 ITGB4 ITGB8 PTK2 FLNA FLNC LAMB2 TNR PPP1R12C | 3.88e-04 | 199 | 265 | 12 | M39402 |
| Pathway | KEGG_FOCAL_ADHESION | ERBB2 MYLK ITGA1 ITGA4 ITGB4 ITGB8 PTK2 FLNA FLNC COL6A6 LAMB2 TNR | 3.88e-04 | 199 | 265 | 12 | M7253 |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 4.11e-04 | 52 | 265 | 6 | M13103 | |
| Pathway | REACTOME_PD_1_SIGNALING | 4.66e-04 | 20 | 265 | 4 | MM15001 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 HIP1 VWA8 INPPL1 ADGRB2 FHIP1B TTC3 TNFRSF21 ITGB4 ITPR3 PLEKHG1 FAT1 PHLDB1 ZNF276 NFATC1 MAD1L1 DTX2 HERC2 DOCK6 HECTD1 LTBP4 ABTB2 HSPG2 FLNA FLNC FRAS1 CDC42BPA LAMB2 FRYL HUWE1 FAAP100 MST1R KMT2D LLGL2 INF2 PCNX1 HMGXB3 LTBP3 SOWAHB HTT | 9.90e-12 | 1105 | 362 | 40 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ERBB2 POU6F2 PDE3B TP53INP1 MYO9A VPS13C ATP9B TTC3 ERBIN ALX4 PTK2 PTK7 PHF2 PHLDB1 MTA3 GNG12 NFATC1 MAD1L1 DOCK6 HECTD1 AGAP1 ANKS1A NSUN5P1 CDC42BPA MRPL42 FRYL HUWE1 SHROOM2 AR FAF1 EEF1A2 YEATS2 ZNF33B DPP9 WDR11 INF2 RASGEF1C MACF1 CAMKMT GREB1 SERINC5 HTT DOP1A ZC3HAV1 | 5.77e-10 | 1489 | 362 | 44 | 28611215 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERBB2 PDE3B MYO9A INPPL1 ERBIN FSIP2 PLEKHG1 PHLDB1 PRMT5 MAD1L1 MAP3K9 KIF14 PLEKHA5 DOCK6 HECTD1 ABTB2 ANKS1A CDC42BPA FRYL SIK3 ECT2 EEF1A1 EEF1A2 ZNF106 MACF1 AKAP11 AKAP1 TP53 PPP1R12C DOP1A SAMD4A ZC3HAV1 | 6.93e-10 | 861 | 362 | 32 | 36931259 |
| Pubmed | Interaction of CD4 with HLA class II antigens and HIV gp120. | 3.42e-09 | 14 | 362 | 6 | 1869305 | |
| Pubmed | HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. | 3.42e-09 | 14 | 362 | 6 | 7512597 | |
| Pubmed | Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. | 3.71e-09 | 24 | 362 | 7 | 15489916 | |
| Pubmed | 5.64e-09 | 15 | 362 | 6 | 8376762 | ||
| Pubmed | 5.64e-09 | 15 | 362 | 6 | 10729169 | ||
| Pubmed | 5.64e-09 | 15 | 362 | 6 | 7602119 | ||
| Pubmed | 5.64e-09 | 15 | 362 | 6 | 1967269 | ||
| Pubmed | Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. | 5.64e-09 | 15 | 362 | 6 | 22860026 | |
| Pubmed | 5.64e-09 | 15 | 362 | 6 | 8168144 | ||
| Pubmed | 5.64e-09 | 15 | 362 | 6 | 3489470 | ||
| Pubmed | 5.64e-09 | 15 | 362 | 6 | 9079699 | ||
| Pubmed | 6.93e-09 | 26 | 362 | 7 | 11827988 | ||
| Pubmed | 8.95e-09 | 16 | 362 | 6 | 1978941 | ||
| Pubmed | 8.95e-09 | 16 | 362 | 6 | 17959659 | ||
| Pubmed | Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. | 8.95e-09 | 16 | 362 | 6 | 2846691 | |
| Pubmed | Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. | 8.95e-09 | 16 | 362 | 6 | 2543930 | |
| Pubmed | ERBB2 VWA8 VPS13C ARHGAP11A MTA3 TMEM131L PLEKHA5 BOP1 DOCK6 ARHGAP11B AGAP1 ANKS1A SDK2 CDC42BPA SMCHD1 FNDC3A SIK3 AFAP1 NUP155 PCNX1 AKAP11 HMGXB3 HERC4 | 1.10e-08 | 529 | 362 | 23 | 14621295 | |
| Pubmed | Keeping the (kinase) party going: SLP-76 and ITK dance to the beat. | 1.23e-08 | 28 | 362 | 7 | 17652306 | |
| Pubmed | IGSF8 VSIG2 PSG6 PTGFRN PTK7 NEGR1 ADGRF5 VSTM5 IGLON5 MXRA8 LRRC4B IL1RAP LRIT1 | 1.75e-08 | 162 | 362 | 13 | 25826454 | |
| Pubmed | 2.04e-08 | 18 | 362 | 6 | 10661406 | ||
| Pubmed | 2.04e-08 | 18 | 362 | 6 | 11118314 | ||
| Pubmed | HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. | 2.04e-08 | 18 | 362 | 6 | 19620308 | |
| Pubmed | 2.65e-08 | 31 | 362 | 7 | 11048639 | ||
| Pubmed | The mouse as a model for the effects of MHC genes on human disease. | B3GALT4 HLA-DMA HLA-DOB HLA-DRB1 HLA-DRB5 PSMB9 APOM AGER ABHD16A | 3.26e-08 | 67 | 362 | 9 | 10871872 |
| Pubmed | 3.36e-08 | 32 | 362 | 7 | 19449444 | ||
| Pubmed | 4.18e-08 | 20 | 362 | 6 | 12427289 | ||
| Pubmed | 4.18e-08 | 20 | 362 | 6 | 7541827 | ||
| Pubmed | HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. | 5.73e-08 | 5 | 362 | 4 | 17559577 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 5.73e-08 | 5 | 362 | 4 | 12629516 | |
| Pubmed | 5.73e-08 | 5 | 362 | 4 | 26751774 | ||
| Pubmed | 5.80e-08 | 21 | 362 | 6 | 21778700 | ||
| Pubmed | 5.80e-08 | 21 | 362 | 6 | 8084338 | ||
| Pubmed | 1.06e-07 | 23 | 362 | 6 | 19770068 | ||
| Pubmed | 1.40e-07 | 24 | 362 | 6 | 18945465 | ||
| Pubmed | 1.70e-07 | 6 | 362 | 4 | 17153701 | ||
| Pubmed | HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. | 1.70e-07 | 6 | 362 | 4 | 14508706 | |
| Pubmed | Interactions of viral protein U (Vpu) with cellular factors. | 3.00e-07 | 27 | 362 | 6 | 20012522 | |
| Pubmed | ZMYM2 TTC3 ERBIN ANKRD28 HERC2 HSPG2 FLNA FLNC LAMB2 HUWE1 FAF1 EEF1A1 PIGQ ZNF106 KMT2D NUP155 TRIM62 MACF1 LTBP3 IL1RAP TP53 RNF111 | 3.37e-07 | 591 | 362 | 22 | 15231748 | |
| Pubmed | 3.94e-07 | 7 | 362 | 4 | 18569076 | ||
| Pubmed | Crystal structure of HLA-DP2 and implications for chronic beryllium disease. | 3.94e-07 | 7 | 362 | 4 | 20356827 | |
| Pubmed | DCBLD1 SEMA3G PTK7 FZD5 PLXNB3 SDK2 SEMA5A CUBN PLXNC1 LRIT1 | 4.38e-07 | 117 | 362 | 10 | 17145500 | |
| Pubmed | Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence. | 7.21e-07 | 31 | 362 | 6 | 21922073 | |
| Pubmed | 7.21e-07 | 31 | 362 | 6 | 26618355 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 21569485 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 30660359 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 3466180 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 2471740 | ||
| Pubmed | Polymorphism in the regulatory region of HLA-DRB genes correlating with haplotype evolution. | 1.12e-06 | 3 | 362 | 3 | 8462990 | |
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 31123786 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 18448518 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 10609818 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 8016840 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 19061288 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 27749841 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 31183372 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 25212604 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 36122208 | ||
| Pubmed | 1.12e-06 | 3 | 362 | 3 | 8672125 | ||
| Pubmed | ATP8B4 PTGFRN PHF2 AHRR SACS WDR35 ADGRF5 DTX2 PRMT7 HECTD1 CEP290 ATP8B2 THOC5 SETD2 ZNF526 WDR11 MACF1 REXO1L1P DOP1A | 1.29e-06 | 493 | 362 | 19 | 15368895 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | ITGB4 ITPR3 HERC2 DOCK6 HECTD1 FLNA CDC42BPA SMCHD1 WRN FRYL EEF1A1 TP53 | 1.59e-06 | 202 | 362 | 12 | 33005030 |
| Pubmed | 2.31e-06 | 10 | 362 | 4 | 12956878 | ||
| Pubmed | Disruption of FAT10-MAD2 binding inhibits tumor progression. | 2.31e-06 | 10 | 362 | 4 | 25422469 | |
| Pubmed | DBH ITGA1 ITGB4 APOM LIPG ANGPTL3 ADGRF5 PZP KNG1 VCAM1 HSPG2 SERPINA6 IGHD | 3.50e-06 | 257 | 362 | 13 | 16335952 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SCN11A VPS13C ITGA1 GSTO2 ITGB8 SLIT2 FAT1 GNG12 UMOD KNG1 CAP1 HSPG2 FLNA COL15A1 CDC42BPA MXRA8 HUWE1 CUBN SHROOM2 ACTR2 TSPAN3 STRIP1 EEF1A1 TGFBR3 SCRN2 CSK CAPN7 SERINC5 | 3.50e-06 | 1016 | 362 | 28 | 19056867 |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | INPPL1 PTGFRN PTK2 PTK7 OSBPL11 DOCK6 HDAC6 LAMB2 LLGL2 AKAP11 HERC4 | 3.86e-06 | 183 | 362 | 11 | 31932471 |
| Pubmed | PDE4B AHI1 TRIM61 ETS1 TTC3 ERBIN ITGB4 PPARGC1A C5orf34 EXOC3L4 OSBPL11 MAP3K9 TMEM131L BOP1 DTX2 FLNA HDAC6 NFKBIZ FRYL HUWE1 CUBN SHROOM2 ZNF750 INF2 MACF1 HMGXB3 CEP295 HERC4 PHACTR1 | 4.14e-06 | 1084 | 362 | 29 | 11544199 | |
| Pubmed | Androgen-induced cell migration: role of androgen receptor/filamin A association. | 4.44e-06 | 4 | 362 | 3 | 21359179 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.44e-06 | 4 | 362 | 3 | 10469592 | |
| Pubmed | 4.44e-06 | 4 | 362 | 3 | 12421908 | ||
| Pubmed | 4.44e-06 | 4 | 362 | 3 | 11375975 | ||
| Pubmed | 4.44e-06 | 4 | 362 | 3 | 18520346 | ||
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 4.44e-06 | 4 | 362 | 3 | 3476943 | |
| Pubmed | 4.44e-06 | 4 | 362 | 3 | 11739414 | ||
| Pubmed | 4.44e-06 | 4 | 362 | 3 | 32341563 | ||
| Pubmed | Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. | 4.44e-06 | 4 | 362 | 3 | 20166740 | |
| Pubmed | 4.44e-06 | 4 | 362 | 3 | 12756263 | ||
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 4.44e-06 | 4 | 362 | 3 | 12144077 | |
| Pubmed | 4.44e-06 | 4 | 362 | 3 | 19081632 | ||
| Pubmed | 4.44e-06 | 4 | 362 | 3 | 11027344 | ||
| Pubmed | DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression. | 4.44e-06 | 4 | 362 | 3 | 2998758 | |
| Pubmed | 4.44e-06 | 4 | 362 | 3 | 26740600 | ||
| Pubmed | 4.44e-06 | 4 | 362 | 3 | 8882725 | ||
| Pubmed | 5.35e-06 | 12 | 362 | 4 | 30013108 | ||
| Pubmed | PSMB9 CHIT1 KIF14 LOXL4 BOP1 PIPSL DOCK6 LTBP4 LAMB2 HUWE1 RFC5 AR EEF1A2 SETD2 PRPF4 RASGEF1C MACF1 TP53 | 5.64e-06 | 496 | 362 | 18 | 31343991 | |
| Pubmed | ADGRB2 PLPPR3 SDK2 CDC42BPA LRRC4B PDHX IL1RAPL1 GCAT PLXNC1 MACF1 UBASH3B | 7.80e-06 | 197 | 362 | 11 | 36604605 | |
| Pubmed | 7.95e-06 | 27 | 362 | 5 | 19604093 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 7.95e-06 | 27 | 362 | 5 | 31541017 | |
| Pubmed | IGSF8 HLA-DRB1 SEMA3G ITGB4 LOXL4 DMBT1 CAP1 HSPG2 RARRES1 LAMB2 DUOX2 ACTR2 EEF1A1 TGFBR3 LTBP3 MUC5AC | 9.40e-06 | 417 | 362 | 16 | 19199708 | |
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 9.59e-06 | 28 | 362 | 5 | 27002738 | |
| Pubmed | MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation. | 1.10e-05 | 5 | 362 | 3 | 24572784 | |
| Pubmed | 1.10e-05 | 5 | 362 | 3 | 12209103 | ||
| Pubmed | HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population. | 1.10e-05 | 5 | 362 | 3 | 17182961 | |
| Pubmed | 1.10e-05 | 5 | 362 | 3 | 11782380 | ||
| Pubmed | 1.10e-05 | 5 | 362 | 3 | 23152536 | ||
| Pubmed | 1.10e-05 | 5 | 362 | 3 | 16916662 | ||
| Pubmed | 1.10e-05 | 5 | 362 | 3 | 8626763 | ||
| Pubmed | 1.10e-05 | 5 | 362 | 3 | 7645219 | ||
| Interaction | GSN interactions | ERBB2 PDE4B CEBPA ESR2 ARHGAP11A PTK2 PLEKHG1 KIF14 FLNA HDAC6 ECT2 AR ACTR2 CSK TP53 HTT | 1.03e-06 | 212 | 351 | 16 | int:GSN |
| Interaction | YWHAE interactions | PDE3B AHI1 MYO9A HLA-DRB1 ESR2 HLA-DRB3 INSIG1 HLA-DRB5 ITGA4 TTC3 ERBIN PHLDB1 MAP3K9 KIF14 PLEKHA5 HECTD1 METAP2 VCAM1 AGAP1 ANKS1A FLNA TRAPPC11 CDC42BPA HDAC6 FRYL HUWE1 SIK3 SHROOM2 ACTR2 FAF1 EEF1A1 EEF1A2 MST1R ZNF750 RIN1 ZNF106 CSK CAPN7 CD274 MACF1 AKAP11 TP53 HTT SAMD4A | 7.87e-06 | 1256 | 351 | 44 | int:YWHAE |
| Interaction | RAC1 interactions | HIP1 CEBPA INPPL1 ESR2 DCBLD1 MCF2 ITGA1 ITGA4 ERBIN ITGB8 PTK2 PLEKHG1 FAT1 OSBPL11 KIF14 PLEKHA5 DOCK6 LTBP4 METAP2 VCAM1 AGAP1 ANKS1A FLNA CDC42BPA HDAC6 HUWE1 ECT2 PDHX EEF1A1 USP6 LLGL2 NUP155 WDR11 INF2 MACF1 LTBP3 IL1RAP HTT ZC3HAV1 | 9.50e-06 | 1063 | 351 | 39 | int:RAC1 |
| Interaction | TOP3B interactions | ERBB2 HIP1 VWA8 INPPL1 ADGRB2 RCC1 FHIP1B TTC3 TNFRSF21 ITGB4 ITPR3 PLEKHG1 FAT1 PHLDB1 ZNF276 GNG12 NFATC1 PRMT5 MAD1L1 KIF14 DTX2 HERC2 DOCK6 HECTD1 LTBP4 ABTB2 HSPG2 FLNA FLNC FRAS1 CDC42BPA WRN LAMB2 FRYL HUWE1 FAAP100 ACTR2 MST1R KMT2D LLGL2 INF2 PCNX1 HMGXB3 LTBP3 SOWAHB TP53 HTT ZC3HAV1 | 1.88e-05 | 1470 | 351 | 48 | int:TOP3B |
| Interaction | YWHAH interactions | PDE3B MYO9A INPPL1 ESR2 ERBIN PLEKHG1 PHLDB1 MAD1L1 MAP3K9 KIF14 PLEKHA5 DCLRE1A DOCK6 HECTD1 AGAP1 ANKS1A TRAPPC11 CDC42BPA CEP290 FRYL HUWE1 SIK3 ECT2 ACTR2 FAF1 EEF1A1 EEF1A2 MST1R RIN1 ZNF106 CSK MACF1 AKAP11 AKAP1 PPP1R12C HTT DOP1A SAMD4A ZC3HAV1 | 2.15e-05 | 1102 | 351 | 39 | int:YWHAH |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | B3GALT4 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 PSMB9 PTK7 ITPR3 APOM AGER DNAH8 ABHD16A ANKS1A ETV7 UNC5CL | 3.06e-06 | 503 | 361 | 16 | chr6p21 |
| Cytoband | 6p21.3 | B3GALT4 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB5 PSMB9 AGER ABHD16A | 3.30e-05 | 250 | 361 | 10 | 6p21.3 |
| Cytoband | 9q31-q33 | 6.17e-05 | 2 | 361 | 2 | 9q31-q33 | |
| GeneFamily | Immunoglobulin like domain containing | SEMA3G PTGFRN PTK7 FCGR2B AGER ADGRF5 IGLON5 VCAM1 HSPG2 SDK2 IL1RAPL1 IL1RAP IGSF21 | 3.26e-06 | 193 | 252 | 13 | 594 |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | IGSF8 ERBB2 ITGA1 ITGA4 ADAM8 PTGFRN TNFRSF21 ITGB4 TNFRSF4 FCGR2B KEL VCAM1 MST1R FCGR2C PLXNC1 TNFRSF8 CD274 FCAMR | 1.12e-05 | 394 | 252 | 18 | 471 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | MYLK VSIG2 PTK7 NEGR1 ADGRF5 VCAM1 HSPG2 SDK2 LRRC4B IL1RAPL1 LRIT1 | 1.64e-05 | 161 | 252 | 11 | 593 |
| GeneFamily | Adenosine receptors|V-set domain containing | IGSF8 VSIG2 PSG6 PTGFRN SIGLEC15 VSTM5 IGLON5 MXRA8 CD274 IGSF21 FCAMR | 1.84e-05 | 163 | 252 | 11 | 590 |
| GeneFamily | C1-set domain containing | 2.38e-05 | 42 | 252 | 6 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 3.13e-05 | 44 | 252 | 6 | 588 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.01e-03 | 181 | 252 | 9 | 694 | |
| GeneFamily | ATPase phospholipid transporting | 1.08e-03 | 15 | 252 | 3 | 1210 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.14e-03 | 4 | 252 | 2 | 628 | |
| GeneFamily | I-set domain containing|IgLON cell adhesion molecules | 1.88e-03 | 5 | 252 | 2 | 1052 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD28 HECTD1 ABTB2 AGAP1 ANKS1A TRPV1 NFKBIZ KANK4 SOWAHB PPP1R12C | 2.17e-03 | 242 | 252 | 10 | 403 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | TPP2 ATP8B4 C5orf22 ACTR5 MYO9A GDAP1 ATP9B ITGA1 FHIP1B PTGFRN TNFRSF21 ITGB8 SORCS1 FAT1 MTA3 GNG12 SACS MAD1L1 TMEM131L HERC2 CAP1 AGAP1 ANKS1A VIPR2 HSPG2 SDK2 ADAMTS1 RFC5 ECT2 TSPAN3 FAF1 AFAP1 BABAM1 WDR11 KANK4 IL1RAP WIPI2 SAMD4A | 1.39e-08 | 1009 | 354 | 38 | M157 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | ERBB2 SEMA3G ITGB4 ITGB8 ITPR3 SLIT2 GNG12 LPCAT2 ANKRD28 PLXNB3 HSPG2 COL15A1 LAMB2 TGFBR3 KANK4 LTBP3 | 8.65e-07 | 268 | 354 | 16 | M45796 |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | VPS13C HLA-DRB1 ESR2 HLA-DRB5 RNF19B CSMD3 ITGB8 ADGRF5 VCAM1 RAET1G ZFPM2 ULBP2 RAET1L | 3.27e-06 | 198 | 354 | 13 | MM17083 |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN | AHI1 VWA8 FHIP1B TTC3 ADAM8 PTK2 ITPR3 FKTN DOCK6 CEP290 SEMA5A FRYL DOP1A | 3.65e-06 | 200 | 354 | 13 | M6018 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPC ZMYM2 ARHGAP11A PTK2 SLIT2 FAT1 SACS MAD1L1 TMEM131L KIF14 ANKRD28 AGAP1 ANKS1A CDC42BPA SMCHD1 WRN SEMA5A FNDC3A FRYL SIK3 TGFBR3 USP6 SETD2 AFAP1 MACF1 AKAP11 IL1RAP HERC4 SAMD4A | 6.25e-06 | 856 | 354 | 29 | M4500 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | TPP2 AHI1 HLA-DMA HLA-DPB1 HLA-DRB1 PSMB9 TTC3 PTK2 SACS FZD5 MAD1L1 KIF14 BOP1 HERC2 ABTB2 AGAP1 FLNC CDC42BPA SMCHD1 MEMO1 PLXNC1 MACF1 HMGXB3 GREB1 SERINC5 SAMD4A PHACTR1 | 1.13e-05 | 790 | 354 | 27 | M12490 |
| Coexpression | GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP | C5orf22 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 ZNF232 FCGR2B MAP3K9 TSPAN3 HARS2 FCGR2C IGHD | 1.75e-05 | 198 | 354 | 12 | M5544 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_AEROCYTE | 2.36e-05 | 87 | 354 | 8 | M45745 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | VWA8 ITGB8 PTK2 PLEKHA5 AGAP1 NOX4 SEMA5A NBEA FAF1 CAMKMT SAMD4A | 2.94e-05 | 176 | 354 | 11 | M39223 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | CENPC VPS13C KIF14 VWA3B WRN FNDC3A FRYL YEATS2 ZNF106 SETD2 MACF1 | 3.62e-05 | 180 | 354 | 11 | M8239 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CPNE2 TPP2 PDE4B MYLK TP53INP1 INPPL1 ERBIN TNFRSF21 ITGB8 PLEKHG1 PHLDB1 NEGR1 LIPG WDR35 ANKRD28 IGLON5 PLXNB3 CARD19 PARP3 WRN CUBN SHROOM2 PIGQ TGFBR3 AFAP1 PLXNC1 PCNX1 CEP295 SERINC5 UBASH3B TNR HTT | 4.44e-05 | 1102 | 354 | 32 | M2369 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GDAP1 MCF2 TTC3 CSMD3 NDST3 FSIP2 PPARGC1A PRDM8 GDAP1L1 CSRNP3 NEGR1 KCNK2 MAP3K9 KCNQ3 TARBP1 AGAP1 PDZD4 COL6A6 NOX4 LRRC4B NBEA AMER3 SIK3 SHROOM2 ZFPM2 STRIP1 EEF1A2 PLXNC1 SERINC5 UBASH3B MUC2 DOP1A | 4.76e-05 | 1106 | 354 | 32 | M39071 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CPNE2 TPP2 PDE4B MYLK TP53INP1 INPPL1 ERBIN TNFRSF21 ITGB8 PLEKHG1 PHLDB1 NEGR1 LIPG WDR35 ANKRD28 IGLON5 PLXNB3 CARD19 PARP3 WRN CUBN SHROOM2 PIGQ TGFBR3 AFAP1 PLXNC1 PCNX1 CEP295 SERINC5 UBASH3B TNR HTT | 6.45e-05 | 1124 | 354 | 32 | MM1070 |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 7.52e-05 | 131 | 354 | 9 | M39232 | |
| Coexpression | SANA_RESPONSE_TO_IFNG_UP | 7.59e-05 | 76 | 354 | 7 | M4551 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2B | MYLK HLA-DMA HLA-DPB1 HLA-DRB1 HLA-DRB5 ITGA4 PTK2 NFATC1 FCGR2B TMEM131L ADGRF5 VCAM1 COL15A1 LAMB2 NFKBIZ CMTR2 | 8.91e-05 | 389 | 354 | 16 | M4995 |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP | 8.96e-05 | 199 | 354 | 11 | M8119 | |
| Coexpression | GSE3982_DC_VS_MAC_LPS_STIM_DN | MAGEA8 INCENP VWA8 RNF19B GNG12 ABTB2 SIK3 CUBN PAPSS2 TGFBR3 ZC3HAV1 | 8.96e-05 | 199 | 354 | 11 | M5390 |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | VPS13C INPPL1 WDR35 OSBPL11 FNDC3A SIK3 THOC5 ZNF106 CSK AKAP11 | 9.18e-05 | 166 | 354 | 10 | M344 |
| Coexpression | DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS | VSIG2 ETS1 SEMA3G PTK2 ITPR3 PLEKHG1 RASIP1 ADGRF5 DOCK6 HSPG2 COL15A1 SHROOM2 RIN1 | 9.30e-05 | 272 | 354 | 13 | MM3634 |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | PDE3B PTK7 AGER MAP3K9 VIPR2 RFC5 PAPSS2 OGG1 GCAT HTT PHACTR1 | 9.37e-05 | 200 | 354 | 11 | M8383 |
| Coexpression | HALLMARK_APICAL_JUNCTION | INPPL1 INSIG1 ITGB4 PTK2 SLIT2 NEGR1 VCAM1 CAP1 FLNC SHROOM2 CD274 | 9.37e-05 | 200 | 354 | 11 | M5915 |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | HLA-DMA HLA-DPB1 INPP5D TMEM131L TARBP1 SMCHD1 HUWE1 AGPS ECT2 AKAP11 RNF111 | 9.37e-05 | 200 | 354 | 11 | M4449 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | AHI1 MYO9A VPS13C ERBIN PTK2 CDC42BPA ADAMTS1 SIK3 CAMKMT SAMD4A | 1.06e-04 | 169 | 354 | 10 | M39230 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIP1 PDE4B TP53INP1 ZNF175 ETS1 MCF2 SEMA3G ITGA4 ITGB8 PLEKHG1 FBXO3 UMOD ADGRF5 KNG1 ANKS1A SEMA5A FNDC3A FRYL SHROOM2 TGFBR3 INF2 KANK4 MACF1 SERINC5 SAMD4A ZC3HAV1 | 1.11e-04 | 854 | 354 | 26 | M1533 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | AHI1 VWA8 ATP9B PPARGC1A KNG1 AGAP1 FRAS1 CASR SIK3 FAF1 CAMKMT | 1.33e-04 | 208 | 354 | 11 | M39233 |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MONOCYTES | 1.52e-04 | 38 | 354 | 5 | M39297 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MYLK PTK7 SLIT2 PZP LTBP4 VCAM1 SDK2 COL6A6 ADAMTS1 MXRA8 SEMA5A PAPSS2 TGFBR3 AFAP1 MACF1 | 7.78e-11 | 199 | 355 | 15 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK PTK7 SLIT2 PZP LTBP4 VCAM1 SDK2 COL6A6 ADAMTS1 MXRA8 SEMA5A PAPSS2 TGFBR3 AFAP1 MACF1 | 7.78e-11 | 199 | 355 | 15 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | MYLK PTK7 SORCS1 NDST3 FAT1 NEGR1 PZP LTBP4 VIPR2 RARRES1 MXRA8 TGFBR3 AFAP1 GAB3 LTBP3 | 8.35e-11 | 200 | 355 | 15 | a799fc7bb83ad0524362cb5010df949741fb7bf3 |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | HIC1 HLA-DOB INSIG1 ITGA4 ADAM8 TNFRSF4 C5orf34 ZNF469 FCGR2B NEGR1 PLEKHA5 IGLON5 SDS PLXNC1 | 2.75e-10 | 183 | 355 | 14 | 20c4d16de7e090df3556a4458f783383a26871b6 |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | PDE3B SORCS1 SLIT2 PHLDB1 LPCAT2 NEGR1 PLEKHA5 LTBP4 ABTB2 AGAP1 COL15A1 NOX4 ZFPM2 TGFBR3 | 5.93e-10 | 194 | 355 | 14 | 234d1494c114cce77c619708bbcd8d5ce805f19b |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK PTK7 SORCS1 FAT1 NEGR1 PZP LTBP4 FLNA RARRES1 ADAMTS1 MXRA8 ZFPM2 TGFBR3 LTBP3 | 8.28e-10 | 199 | 355 | 14 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK PTK7 SLIT2 PZP LTBP4 VCAM1 SDK2 COL6A6 ADAMTS1 MXRA8 SEMA5A PAPSS2 AFAP1 MACF1 | 8.84e-10 | 200 | 355 | 14 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK PTK7 SLIT2 PZP LTBP4 VCAM1 SDK2 COL6A6 ADAMTS1 MXRA8 SEMA5A PAPSS2 AFAP1 MACF1 | 8.84e-10 | 200 | 355 | 14 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK ITGA1 PTK7 SORCS1 FAT1 NEGR1 PZP LTBP4 FLNA RARRES1 ADAMTS1 MXRA8 TGFBR3 LTBP3 | 8.84e-10 | 200 | 355 | 14 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK PTK7 SLIT2 PZP LTBP4 VCAM1 SDK2 COL6A6 ADAMTS1 MXRA8 SEMA5A PAPSS2 AFAP1 MACF1 | 8.84e-10 | 200 | 355 | 14 | 44a68bacdb3d5bf563bd35952176995850933a81 |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | MYLK ITGA1 PTK7 FAT1 NEGR1 PZP LTBP4 RARRES1 ADAMTS1 MXRA8 LRRC4B NBEA TGFBR3 LTBP3 | 8.84e-10 | 200 | 355 | 14 | a9ff3210127000b3dd9e97136163c98c2b0817d7 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK PTK7 SLIT2 PZP LTBP4 VCAM1 SDK2 COL6A6 ADAMTS1 MXRA8 SEMA5A PAPSS2 AFAP1 MACF1 | 8.84e-10 | 200 | 355 | 14 | dc61016c61729f69649cfb21f6264e685ce83dea |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HIC1 ATP8B4 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB5 SIGLEC15 LPCAT2 SDS YEATS2 PLXNC1 IGSF21 ZC3HAV1 | 2.78e-09 | 182 | 355 | 13 | 7909089ed6325c44edd6f9b7e8b1d542398222ea |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HIC1 ATP8B4 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB5 SIGLEC15 LPCAT2 SDS YEATS2 PLXNC1 IGSF21 ZC3HAV1 | 2.78e-09 | 182 | 355 | 13 | 4a85429d365c4b2d73fc921f261b4b7635ac40bd |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HIC1 ATP8B4 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB5 SIGLEC15 LPCAT2 SDS YEATS2 PLXNC1 IGSF21 ZC3HAV1 | 2.78e-09 | 182 | 355 | 13 | 53213af34af3337f5edc734d3b7b79e4349eac0d |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYLK ITGA1 FAT1 GNG12 NEGR1 PZP LTBP4 RARRES1 ADAMTS1 ZFPM2 TGFBR3 ADAMTS6 LTBP3 | 3.39e-09 | 185 | 355 | 13 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 |
| ToppCell | LAM-Myeloid-DC|LAM / Condition, Lineage and Cell class | PDE4B ATP8B4 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 ADAM8 IL22RA2 FCGR2B SDS PLXNC1 IGSF21 | 4.11e-09 | 188 | 355 | 13 | b4140110c2f7d25fd8a0d2749e33e02003ac4bf2 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MYLK PTK7 FAT1 PHLDB1 GNG12 ABTB2 FLNA FLNC COL15A1 ADAMTS1 TGFBR3 ADAMTS6 UBASH3B | 4.11e-09 | 188 | 355 | 13 | 4d1e5f85342ae550086609d7680e32730b78b5d2 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDE3A MYLK ITGA1 SLIT2 FAT1 GNG12 NEGR1 PZP LTBP4 VIPR2 ADAMTS1 ZFPM2 TGFBR3 | 4.39e-09 | 189 | 355 | 13 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDE3A MYLK ITGA1 FAT1 GNG12 NEGR1 PZP LTBP4 VIPR2 FLNA ADAMTS1 ZFPM2 TGFBR3 | 5.31e-09 | 192 | 355 | 13 | 992d08092edbc68c47b945deb8708379738c239a |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | HLA-DMA HLA-DPB1 HLA-DRB1 DDIT4L ETS1 ITGA1 ITGA4 PLAAT2 VCAM1 LLGL2 ADAMTS6 GAB3 TRBC2 | 5.65e-09 | 193 | 355 | 13 | 778fcf8448e81fe18972d97ea8a30ab036d16fe5 |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | PDE4B ATP8B4 HLA-DMA HLA-DOB HLA-DPB1 INPP5D HLA-DRB1 HLA-DRB5 ITGA4 ADAM8 FCGR2B SDS PLXNC1 | 6.01e-09 | 194 | 355 | 13 | 024568d8a862f0fe4da1f66a58c6e71f0e8279f3 |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | AHI1 TP53INP1 HLA-DMA HLA-DPB1 HLA-DRB1 PTK2 PLEKHG1 WDR35 TMEM131L SIK3 IGHD SOCS4 PHACTR1 | 6.01e-09 | 194 | 355 | 13 | d852aebf7a763b9a776c4570711f0c759f591910 |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | PDE4B ATP8B4 HLA-DMA HLA-DOB HLA-DPB1 INPP5D HLA-DRB1 HLA-DRB5 ITGA4 ADAM8 FCGR2B SDS PLXNC1 | 6.01e-09 | 194 | 355 | 13 | 74d588de2f84a4ef112fd642f7e112a542d5ef11 |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | HLA-DPB1 HLA-DRB1 HLA-DRB5 ITGA4 ERBIN PLEKHA5 PZP AGAP1 PDZD4 FLNA TGFBR3 GAB3 MACF1 | 6.40e-09 | 195 | 355 | 13 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HIC1 HLA-DMA HLA-DPB1 HLA-DRB1 HLA-DRB5 RNF19B ITGA4 ADAM8 ZNF469 IL22RA2 LPCAT2 IGLON5 SDS | 7.23e-09 | 197 | 355 | 13 | 515a2d0ee2bd3fc0a5a0c315e2b0c752e6af7406 |
| ToppCell | wk_08-11-Hematologic-Myeloid-APOE+_Mac1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | CEBPA HLA-DMA HLA-DPB1 HLA-DRB1 HLA-DRB5 TNFRSF4 NFATC1 KEL OPLAH ANKS1A FCGR2C CSK IGSF21 | 7.23e-09 | 197 | 355 | 13 | 121ec3f6d978de2f6c2cc397f7327d2e5587ab8b |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HIC1 HLA-DMA HLA-DPB1 HLA-DRB1 HLA-DRB5 RNF19B ITGA4 ADAM8 ZNF469 IL22RA2 LPCAT2 IGLON5 SDS | 7.23e-09 | 197 | 355 | 13 | bfa04e5f4156a01df4217b1f59676edb0a7563e1 |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HIC1 HLA-DMA HLA-DPB1 HLA-DRB1 HLA-DRB5 RNF19B ITGA4 ADAM8 ZNF469 IL22RA2 LPCAT2 IGLON5 SDS | 7.23e-09 | 197 | 355 | 13 | 4fccdc69ab4b966de6465f06677435e6f6e6abcd |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK PTK7 SLIT2 PZP LTBP4 VCAM1 SDK2 COL6A6 ADAMTS1 MXRA8 SEMA5A AFAP1 MACF1 | 8.17e-09 | 199 | 355 | 13 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK PTK7 SLIT2 PZP LTBP4 VCAM1 COL6A6 ADAMTS1 MXRA8 SEMA5A PAPSS2 AFAP1 MACF1 | 8.67e-09 | 200 | 355 | 13 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK ITGA1 FAT1 NEGR1 PZP LTBP4 FLNA RARRES1 ADAMTS1 MXRA8 ZFPM2 TGFBR3 LTBP3 | 8.67e-09 | 200 | 355 | 13 | 08bf8c00eee6468215edb3611296bfc8784c4d56 |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | MYLK ITGA1 FAT1 NEGR1 PZP LTBP4 FLNA RARRES1 ADAMTS1 MXRA8 ZFPM2 TGFBR3 LTBP3 | 8.67e-09 | 200 | 355 | 13 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | FAT1 GNG12 VCAM1 VIPR2 FLNC RARRES1 WT1 RAET1G ZFPM2 MTMR7 AFAP1 KLK8 | 2.04e-08 | 177 | 355 | 12 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ATP8B4 CEBPA HLA-DMA HLA-DPB1 HLA-DRB1 HLA-DRB5 SDS FCGR2C TNFRSF8 CD274 GAB3 IGSF21 | 2.31e-08 | 179 | 355 | 12 | ae9d90a4eac2cfa545a764df84914c5801544278 |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | SLIT2 FAT1 VCAM1 VIPR2 FLNC RARRES1 ETV7 WT1 SEMA5A ZFPM2 AFAP1 KLK8 | 2.46e-08 | 180 | 355 | 12 | 1fa54bf4dba72866b2295639d991af639341bc08 |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | HIC1 HLA-DOB INSIG1 ADAM8 TNFRSF4 C5orf34 FCGR2B NEGR1 PLEKHA5 IGLON5 SDS PLXNC1 | 2.78e-08 | 182 | 355 | 12 | ee137574b8f0e684a4a7cb26226877c471cae433 |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | SLIT2 FAT1 VCAM1 VIPR2 FLNC RARRES1 ETV7 WT1 SEMA5A ZFPM2 AFAP1 KLK8 | 2.95e-08 | 183 | 355 | 12 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | SLIT2 PHLDB1 NEGR1 LTBP4 VIPR2 COL15A1 RARRES1 MXRA8 NOX4 ZFPM2 TGFBR3 GREB1 | 3.13e-08 | 184 | 355 | 12 | 2b7e6f91e11c228f0521e099886867d9e998e78d |
| ToppCell | (1)_B_CD27neg|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | PDE4B HLA-DMA HLA-DOB INPP5D HLA-DRB1 HLA-DRB5 ITGA4 FCGR2B P2RY8 IGHD TRBC2 PHACTR1 | 3.53e-08 | 186 | 355 | 12 | 646389147189760e9493c4f50f9583959ef0ee26 |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | ITGB8 FAT1 KCNQ3 PLEKHA5 VCAM1 AGAP1 NOX4 SEMA5A CUBN AR NKAIN4 SAMD4A | 4.21e-08 | 189 | 355 | 12 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5-_Mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | PDE4B HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 PSMB9 PLEKHG1 P2RY8 CSK IGHD TRBC2 | 4.47e-08 | 190 | 355 | 12 | ade43d1d1f8909b8526a23152acf3c26f160f836 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MYLK ITGB8 FAT1 KCNQ3 VCAM1 AGAP1 NFKBIZ SEMA5A AR FAM135B NKAIN4 SAMD4A | 4.73e-08 | 191 | 355 | 12 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | PDE4B HLA-DOB HLA-DPB1 PLEKHG1 FCGR2B TSPAN3 EEF1A1 CSK ADAMTS6 IGHD LTBP3 TRBC2 | 5.01e-08 | 192 | 355 | 12 | 5d6569b0f879729aa89d4498c9c886ac9050be13 |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ETS1 DCBLD1 ITGA1 ERBIN PLEKHG1 RASIP1 FCGR2B ADGRF5 HSPG2 ADAMTS1 PLXNC1 MACF1 | 5.31e-08 | 193 | 355 | 12 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | HIC1 ATP8B4 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 INSIG1 HLA-DRB5 ADAM8 FCGR2B SDS PLXNC1 | 5.31e-08 | 193 | 355 | 12 | c97f9b13057f803df63c696c6175ef8e0aba6fa7 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | PDE4B TP53INP1 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 PLEKHG1 SMCHD1 EEF1A1 IGHD PHACTR1 | 5.31e-08 | 193 | 355 | 12 | f4135615ee0118eec9e221becdd67888e0c2a112 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | PDE4B TP53INP1 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 PLEKHG1 SMCHD1 EEF1A1 IGHD PHACTR1 | 5.31e-08 | 193 | 355 | 12 | ac227ddabfb3f021b1b39dba73f898517cd5a58e |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PDE4B HLA-DMA HLA-DOB HLA-DPB1 INPP5D HLA-DRB1 HLA-DRB5 FCGR2B P2RY8 IGHD TRBC2 PHACTR1 | 5.31e-08 | 193 | 355 | 12 | 8d88f3b0d08f9dbae26ee122dbd43f06e2cc3f67 |
| ToppCell | LAM-Myeloid-DC|Myeloid / Condition, Lineage and Cell class | PDE4B ATP8B4 HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 ADAM8 IL22RA2 FCGR2B SDS PLXNC1 IGSF21 | 5.31e-08 | 193 | 355 | 12 | f665cce40053ae5d6e28f9f70ddf78e8598c9514 |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic|Liver / Manually curated celltypes from each tissue | HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 TNFRSF21 PTK2 FCGR2B NEGR1 SDS INF2 PHACTR1 | 5.62e-08 | 194 | 355 | 12 | e6391bc7073831847c469ef0b0c437118e1f151f |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ITGB8 PTK2 PPARGC1A FAT1 GNG12 PLEKHA5 ABTB2 AGAP1 FRAS1 NOX4 CUBN LLGL2 | 5.62e-08 | 194 | 355 | 12 | 7002937e8903e037332a215d00fbc7c7843b33f2 |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-CD5-_Mature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | PDE4B HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 PLEKHG1 FCGR2B P2RY8 CSK IGHD TRBC2 | 5.95e-08 | 195 | 355 | 12 | fe3f978820a63c26a537d97e69f7999dd60bb0ea |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HIC1 PDE4B ATP8B4 HLA-DMA HLA-DPB1 HLA-DRB1 INSIG1 IL22RA2 FCGR2B SDS PLXNC1 PHACTR1 | 5.95e-08 | 195 | 355 | 12 | c26c62522b6e0599f6a1256fefe26e1ed9badcc2 |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HIC1 PDE4B ATP8B4 HLA-DMA HLA-DPB1 HLA-DRB1 INSIG1 IL22RA2 FCGR2B SDS PLXNC1 PHACTR1 | 5.95e-08 | 195 | 355 | 12 | 60ba7be0c333ddc57885263a1103faffe06051c7 |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDE4B ATP8B4 HLA-DMA HLA-DPB1 HLA-DRB1 HLA-DRB5 ITGA4 LPCAT2 FCGR2B PLXNC1 IGSF21 PHACTR1 | 5.95e-08 | 195 | 355 | 12 | bbf5f79be4fcea754328f1af7ee5625075248100 |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDE4B ATP8B4 HLA-DMA HLA-DPB1 HLA-DRB1 HLA-DRB5 ITGA4 LPCAT2 FCGR2B PLXNC1 IGSF21 PHACTR1 | 5.95e-08 | 195 | 355 | 12 | 9cfbdb528088ad0ab100c7431c7d8f140a846de8 |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDE4B ATP8B4 HLA-DMA HLA-DPB1 HLA-DRB1 HLA-DRB5 ITGA4 LPCAT2 FCGR2B PLXNC1 IGSF21 PHACTR1 | 5.95e-08 | 195 | 355 | 12 | 66f3b3e15eaa21bc7cf2f204cac81de1a160a748 |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | PDE3B SLIT2 PHLDB1 LPCAT2 NEGR1 LTBP4 ABTB2 AGAP1 COL15A1 NOX4 NFKBIZ TGFBR3 | 5.95e-08 | 195 | 355 | 12 | a78b605b49acd8c9d68716266ca269dafcd910b9 |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDE4B ATP8B4 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 ITGA4 LPCAT2 FCGR2B PLXNC1 PHACTR1 | 5.95e-08 | 195 | 355 | 12 | 7dd0cb8f3753fe761fac200cbd161708b6528c51 |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HIC1 PDE4B ATP8B4 HLA-DMA HLA-DPB1 HLA-DRB1 INSIG1 IL22RA2 FCGR2B SDS PLXNC1 PHACTR1 | 5.95e-08 | 195 | 355 | 12 | d67950679ccb508016352e9cb4c675bd09eaac5b |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HIC1 PDE4B HLA-DMA HLA-DPB1 HLA-DRB1 HLA-DRB5 RNF19B ITGA4 ZNF469 IL22RA2 IGLON5 SDS | 6.29e-08 | 196 | 355 | 12 | 9c942bf9fc78caa173d2c7de5fe4c17f076c623b |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | HLA-DOB HLA-DPB1 INPP5D HLA-DRB1 PTK7 ZNF469 TARBP1 CAP1 ACTR2 TSPAN3 PLXNC1 AKAP11 | 6.29e-08 | 196 | 355 | 12 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DCBLD1 ITGA1 PLEKHG1 RASIP1 FCGR2B ADGRF5 LTBP4 HSPG2 ADAMTS1 TGFBR3 PLXNC1 MACF1 | 6.65e-08 | 197 | 355 | 12 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DCBLD1 ITGA1 PLEKHG1 RASIP1 FCGR2B ADGRF5 LTBP4 HSPG2 ADAMTS1 TGFBR3 PLXNC1 MACF1 | 6.65e-08 | 197 | 355 | 12 | deefb492b5f0e6014144bd465c4a6ae4206e8739 |
| ToppCell | MS-IIF-Lymphocyte-B-B_intermediate|IIF / Disease, condition lineage and cell class | PDE4B HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 PLEKHG1 FCGR2B DNAH8 TSPAN3 IGHD PHACTR1 | 7.03e-08 | 198 | 355 | 12 | d6b533c5e1d55e13b1e87ce3dbacb1564bcdcc64 |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DCBLD1 ITGA1 PLEKHG1 RASIP1 FCGR2B ADGRF5 LTBP4 HSPG2 ADAMTS1 TGFBR3 PLXNC1 MACF1 | 7.03e-08 | 198 | 355 | 12 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 |
| ToppCell | severe-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | PDE4B HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 PTK2 PLEKHG1 FCGR2B KCNK2 TSPAN3 ADAMTS6 | 7.43e-08 | 199 | 355 | 12 | 17283d75a2a900369f63ed02996e7ede97f46140 |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | PDE3B SPEF2 ITGA4 PTK2 AGER ADGRF5 FRAS1 LAMB2 PAPSS2 NKAIN4 MACF1 LTBP3 | 7.43e-08 | 199 | 355 | 12 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK FAT1 PZP LTBP4 FLNA RARRES1 ADAMTS1 MXRA8 LAMB2 ZFPM2 TGFBR3 LTBP3 | 7.43e-08 | 199 | 355 | 12 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | PDE3A MYLK ITGA1 FAT1 NEGR1 LIPG PZP FLNA RARRES1 ADAMTS1 ZFPM2 TGFBR3 | 7.85e-08 | 200 | 355 | 12 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | MYLK ITGA1 FAT1 PZP FLNA RARRES1 ADAMTS1 MXRA8 LAMB2 ZFPM2 TGFBR3 LTBP3 | 7.85e-08 | 200 | 355 | 12 | 593bf6a7c557437db9a9249a5058a46014179ef6 |
| ToppCell | severe-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | PDE4B TP53INP1 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 PLEKHG1 FCGR2B SDK2 SMCHD1 PHACTR1 | 7.85e-08 | 200 | 355 | 12 | 0e86f52b6e146d9bbc728d8fb176fc2b53696558 |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | PDE3A MYLK ITGA1 ITGA4 SLIT2 FAT1 NEGR1 LIPG DOCK6 VIPR2 ADAMTS1 NBEA | 7.85e-08 | 200 | 355 | 12 | 69edc375d85689300d1dbc1217fedc40063ecdcb |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDE3A MYLK ITGA1 ITGA4 TNFRSF21 SLIT2 FAT1 LIPG PZP VIPR2 COL6A6 ADAMTS1 | 7.85e-08 | 200 | 355 | 12 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MYLK FAT1 NEGR1 PZP LTBP4 FLNA RARRES1 ADAMTS1 MXRA8 ZFPM2 TGFBR3 LTBP3 | 7.85e-08 | 200 | 355 | 12 | 87827041663013f5e7273168dc8709d69840e7ce |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK PTK7 SLIT2 PZP LTBP4 VCAM1 SDK2 COL6A6 MXRA8 SEMA5A AFAP1 MACF1 | 7.85e-08 | 200 | 355 | 12 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | AHI1 MYLK FAT1 PZP LTBP4 FLNA RARRES1 ADAMTS1 LAMB2 ZFPM2 TGFBR3 LTBP3 | 7.85e-08 | 200 | 355 | 12 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | AHI1 MYLK FAT1 PZP LTBP4 FLNA RARRES1 ADAMTS1 MXRA8 ZFPM2 TGFBR3 LTBP3 | 7.85e-08 | 200 | 355 | 12 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e |
| ToppCell | Biopsy_Other_PF-Immune-cDCs|Biopsy_Other_PF / Sample group, Lineage and Cell type | ATP8B4 HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 INSIG1 HLA-DRB5 ITGA4 ADAM8 IL22RA2 FCGR2B IGLON5 | 7.85e-08 | 200 | 355 | 12 | 8e455f685f0a9c63e83d6d339d7767f0e9841c6e |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | PDE3A MYLK ITGA1 FAT1 NEGR1 PZP FLNA RARRES1 ADAMTS1 MXRA8 TGFBR3 LTBP3 | 7.85e-08 | 200 | 355 | 12 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | PDE4B HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 ITGA4 ADAM8 IL22RA2 FCGR2B IGLON5 PHACTR1 | 7.85e-08 | 200 | 355 | 12 | 0cb6e65f9efe1d4fd18b8ef4333cc39956cafdad |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | PDE3B SORCS1 SLIT2 PHLDB1 NEGR1 LTBP4 ABTB2 COL15A1 RARRES1 DUOX2 NOX4 | 1.20e-07 | 169 | 355 | 11 | 6373562ab3b1765060212a6a53d6543e7e942e80 |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | HIC1 HLA-DMA HLA-DPB1 HLA-DRB1 INSIG1 HLA-DRB5 CCDC168 IL22RA2 FCGR2B IGLON5 PHACTR1 | 1.28e-07 | 170 | 355 | 11 | 403b6b749d70d845838dcda7daf99971b50792a2 |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | HLA-DMA HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB5 PTK2 PLEKHG1 FCGR2B SDK2 IGHD PHACTR1 | 1.36e-07 | 171 | 355 | 11 | fcc31a9a69f96de10d1324a5a4fbfe4289bf4984 |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VPS13C PHF2 FRAS1 SDK2 FRYL CAPN7 PITPNM3 PCNX1 AKAP11 DOP1A PHACTR1 | 1.62e-07 | 174 | 355 | 11 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | POU6F2 MYLK DCBLD1 CCDC168 ADCY8 PRDM8 ADGRF5 VIPR2 PAPSS2 ROS1 IL1RAP | 1.62e-07 | 174 | 355 | 11 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | TRIM61 ADGRB2 LTBP4 FLNC FRAS1 RARRES1 COL6A6 WT1 IL1RAPL1 MST1R NKAIN4 | 2.03e-07 | 178 | 355 | 11 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PHF2 FRAS1 SDK2 COL6A6 CEP290 PAPSS2 CAPN7 PITPNM3 PCNX1 AKAP11 PHACTR1 | 2.03e-07 | 178 | 355 | 11 | fcbbcc44271515de1969b4732b6441c012693d5f |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | TRIM61 ADGRB2 LTBP4 FLNC FRAS1 RARRES1 COL6A6 WT1 IL1RAPL1 MST1R NKAIN4 | 2.03e-07 | 178 | 355 | 11 | c413861148129be1ee94f2ceb5999840217eebe5 |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | PDE3A SEMA3G ITGB4 PTK2 PLEKHG1 RASIP1 ADGRF5 DOCK6 HSPG2 ADAMTS1 ADAMTS6 | 2.15e-07 | 179 | 355 | 11 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | PDE3B SORCS1 SLIT2 LPCAT2 NEGR1 LTBP4 COL15A1 COL6A6 MXRA8 NOX4 TGFBR3 | 2.15e-07 | 179 | 355 | 11 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | POU6F2 ITGA1 ITGB8 TMEM130 FAT1 CFAP54 VCAM1 WT1 ZFPM2 IL1RAP PHACTR1 | 2.41e-07 | 181 | 355 | 11 | 5f2d3a08577c440c944778d07aa993c6e7873f3d |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | POU6F2 ITGA1 ITGB8 TMEM130 FAT1 CFAP54 VCAM1 WT1 ZFPM2 IL1RAP PHACTR1 | 2.41e-07 | 181 | 355 | 11 | c7c5f7d4c397b4613c772413a0a679377efffff3 |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DBH CSMD3 SLIT2 PLXNB3 IL1RAPL1 NKAIN4 RASGEF1C KLK8 KANK4 GREB1 IGSF21 | 2.54e-07 | 182 | 355 | 11 | a512863304fad80acaab60a8c6107eb7c9cbac99 |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ETS1 ITGA1 PLEKHG1 RASIP1 FCGR2B ADGRF5 LTBP4 HSPG2 MXRA8 TGFBR3 PLXNC1 | 2.69e-07 | 183 | 355 | 11 | 709a486154b3157427deb3b8886b63ac39ea42dd |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ETS1 ITGA1 PLEKHG1 RASIP1 FCGR2B ADGRF5 LTBP4 HSPG2 MXRA8 TGFBR3 PLXNC1 | 2.69e-07 | 183 | 355 | 11 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 |
| ToppCell | cellseq2-Immune-Lymphocytic_B-Lymphocytic_B-B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | HLA-DMA HLA-DOB HLA-DPB1 INPP5D HLA-DRB1 HLA-DRB5 P2RY8 CSK IGHD TNR PHACTR1 | 2.84e-07 | 184 | 355 | 11 | efcd643324ccd212350dc6a27f40efbb666d557b |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | ATP8B4 VPS13C ITGA4 TMEM131L KIF14 SMCHD1 FRYL HUWE1 KMT2D NUP155 MACF1 | 3.00e-07 | 185 | 355 | 11 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | SLIT2 FAT1 VCAM1 FLNC RARRES1 WT1 RAET1G SEMA5A ZFPM2 AFAP1 KLK8 | 3.00e-07 | 185 | 355 | 11 | 23579988036fc1925992c31919750f9b3fe9f790 |
| Drug | trypanothione disulfide | ITGA1 ITGA4 ADAM8 ITGB4 PTK2 ADHFE1 VCAM1 ADAMTS1 LAMB2 FNDC3A SERPINA6 SERINC5 FCAMR | 2.84e-07 | 140 | 352 | 13 | CID000115098 |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A | PDE3B ABCA12 RNF19B ZMYM2 BBS9 TNFRSF21 ACTL8 PLAAT2 MAP3K9 ADGRF5 CEP290 RIN1 AFAP1 PCNX1 | 2.55e-06 | 197 | 352 | 14 | 1506_UP |
| Drug | Org 9935 | 4.56e-06 | 17 | 352 | 5 | CID000131100 | |
| Drug | Etoposide | TPP2 ERBB2 HIC1 PDE4B AHI1 C5orf22 CEBPA ESR2 INSIG1 ZNF232 RASIP1 PPARGC1A FZD5 ANKRD28 VCAM1 FLNC COL15A1 WRN PAPSS2 OGG1 AR ZNF750 CD274 MACF1 TP53 | 5.54e-06 | 587 | 352 | 25 | ctd:D005047 |
| Disease | FEV/FEC ratio | PDE3A ATP8B4 VPS13C SPEF2 DDIT4L DCBLD1 DBH ITGA1 ITGB8 ADCY8 PTK2 PHF2 PPARGC1A C5orf34 NFATC1 FCGR2B NEGR1 AGER DMBT1 PCDH10 LTBP4 METAP2 HSPG2 FRAS1 COL15A1 ADAMTS1 PDHX TSPAN3 FAF1 TGFBR3 ZNF106 FCGR2C AFAP1 LLGL2 RASGEF1C LTBP3 UBASH3B | 1.62e-07 | 1228 | 345 | 37 | EFO_0004713 |
| Disease | Astrocytosis | 1.17e-06 | 17 | 345 | 5 | C3887640 | |
| Disease | Gliosis | 1.17e-06 | 17 | 345 | 5 | C0017639 | |
| Disease | Autistic Disorder | POU6F2 PDE4B AHI1 VWA8 HLA-DRB1 ITGA4 CSMD3 PCDH10 AGAP1 SEMA5A NBEA AR IL1RAPL1 | 1.40e-05 | 261 | 345 | 13 | C0004352 |
| Disease | eosinophil count | RASGRP4 CEBPA TP53INP1 HLA-DOB HLA-DPB1 INPP5D HLA-DRB1 SPEF2 HLA-DRB3 ETS1 PSMB9 PLPPR3 ITGA4 PTGFRN ITGB8 TNFRSF4 ITPR3 VWA3B LTBP4 VCAM1 FLNA P2RY8 CASR SIK3 TSPAN3 SETD2 NANOS2 TMEM232 PLXNC1 TNFRSF8 PCNX1 LTBP3 FUT5 MUC2 MUC5AC TP53 ZC3HAV1 | 1.40e-05 | 1488 | 345 | 37 | EFO_0004842 |
| Disease | Malignant Cystosarcoma Phyllodes | 1.56e-05 | 5 | 345 | 3 | C0600066 | |
| Disease | Phyllodes Tumor | 1.56e-05 | 5 | 345 | 3 | C0010701 | |
| Disease | coronary artery disease (is_implicated_in) | 2.35e-05 | 100 | 345 | 8 | DOID:3393 (is_implicated_in) | |
| Disease | multiple sclerosis | HIC1 PDE4B AHI1 CEBPA VWA8 HLA-DRB1 SPEF2 ETS1 TTC34 PTGFRN ADCY8 PHLDB1 IL22RA2 LIPG VCAM1 ETV7 TGFBR3 PLXNC1 UBASH3B ZC3HAV1 | 2.71e-05 | 594 | 345 | 20 | MONDO_0005301 |
| Disease | systemic lupus erythematosus | ERBB2 HIP1 AHI1 HLA-DOB HLA-DPB1 HLA-DRB1 HLA-DRB3 HLA-DRB5 ETS1 PSMB9 PHLDB1 NFATC1 FCGR2B NEGR1 TARBP1 ANKS1A TRAPPC11 ETV7 CASR RFC5 PDHX FCGR2C CSK SEC14L2 | 2.77e-05 | 799 | 345 | 24 | MONDO_0007915 |
| Disease | Malignant neoplasm of breast | MAGEA1 ERBB2 HIC1 ESR2 ARHGAP11A TTC3 SORCS1 C5orf34 ADHFE1 FKTN OSBPL11 HERC2 PDZD4 FLNA ADAMTS1 C1orf87 WT1 SIK3 CUBN SHROOM2 ECT2 AR THOC5 SETD2 KMT2D LLGL2 MACF1 TP53 DOP1A | 2.92e-05 | 1074 | 345 | 29 | C0006142 |
| Disease | Parkinson's disease (is_implicated_in) | 3.08e-05 | 76 | 345 | 7 | DOID:14330 (is_implicated_in) | |
| Disease | extranodal nasal NK/T cell lymphoma | 3.09e-05 | 6 | 345 | 3 | MONDO_0019472 | |
| Disease | Liver carcinoma | MAGEA1 CEBPA DBH ARHGAP11A PTK2 SLIT2 KIF14 PZP VCAM1 COL15A1 ADAMTS1 ECT2 AR TH PITPNM3 CD274 IL1RAP TP53 | 3.46e-05 | 507 | 345 | 18 | C2239176 |
| Disease | gestational age | 3.76e-05 | 138 | 345 | 9 | EFO_0005112 | |
| Disease | retinal vasculature measurement | PDE3A PDE4B HLA-DRB1 HLA-DRB5 ITGA1 ZNRF4 PLEKHG1 RASIP1 HERC2 METAP2 VIPR2 HSPG2 CDC42BPA STRIP1 TGFBR3 ZNF106 CSK LTBP3 | 4.45e-05 | 517 | 345 | 18 | EFO_0010554 |
| Disease | Eczema, allergic rhinitis | AHI1 CEBPA HLA-DOB HLA-DPB1 INPP5D HLA-DRB1 HLA-DRB3 ETS1 ITGB8 COL15A1 TNFRSF8 | 5.02e-05 | 215 | 345 | 11 | EFO_0005854, HP_0000964 |
| Disease | severe acute respiratory syndrome, COVID-19 | INPP5D SPEF2 GDAP1 BBS9 PPARGC1A OSBPL11 ABTB2 WRN P2RY8 ZFPM2 IL1RAPL1 TGFBR3 ULBP2 RAET1L LTBP3 TNR | 8.52e-05 | 447 | 345 | 16 | EFO_0000694, MONDO_0100096 |
| Disease | Graves' disease (is_implicated_in) | 8.82e-05 | 39 | 345 | 5 | DOID:12361 (is_implicated_in) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 1.26e-04 | 9 | 345 | 3 | EFO_0009824 | |
| Disease | cystitis (is_marker_for) | 1.36e-04 | 2 | 345 | 2 | DOID:1679 (is_marker_for) | |
| Disease | aortic disease (biomarker_via_orthology) | 1.36e-04 | 2 | 345 | 2 | DOID:520 (biomarker_via_orthology) | |
| Disease | Radiation-Induced Cancer | 1.36e-04 | 2 | 345 | 2 | C0751366 | |
| Disease | level of UL16-binding protein 6 in blood serum | 1.36e-04 | 2 | 345 | 2 | OBA_2043185 | |
| Disease | Neoplasms, Radiation-Induced | 1.36e-04 | 2 | 345 | 2 | C0027666 | |
| Disease | Hantavirus hemorrhagic fever with renal syndrome (is_implicated_in) | 1.36e-04 | 2 | 345 | 2 | DOID:11266 (is_implicated_in) | |
| Disease | basophil percentage of leukocytes | RASGRP4 HIP1 ATP8B4 AHI1 CEBPA SPEF2 ETS1 ZNF469 FCGR2B FCGR2C PHACTR1 | 1.49e-04 | 243 | 345 | 11 | EFO_0007992 |
| Disease | primary biliary cirrhosis | 1.78e-04 | 133 | 345 | 8 | EFO_1001486 | |
| Disease | melanoma | MAGEA1 INCENP DDIT4L DCBLD1 MAP3K9 HDAC6 CUBN IL1RAPL1 RIN1 ROS1 TP53 | 1.78e-04 | 248 | 345 | 11 | C0025202 |
| Disease | uremia (biomarker_via_orthology) | 1.79e-04 | 10 | 345 | 3 | DOID:4676 (biomarker_via_orthology) | |
| Disease | aspartate aminotransferase measurement | PDE3A HLA-DPB1 HLA-DRB1 HLA-DRB3 ALKBH5 RASIP1 PPARGC1A FCGR2B LOXL4 ABTB2 AGAP1 NSUN5P1 NOX4 CUBN SERPINA6 HARS2 FCGR2C WDR11 ADAMTS6 HMGXB3 UBASH3B IGSF21 TP53 SAMD4A | 1.84e-04 | 904 | 345 | 24 | EFO_0004736 |
| Disease | brain ischemia (biomarker_via_orthology) | 2.01e-04 | 102 | 345 | 7 | DOID:2316 (biomarker_via_orthology) | |
| Disease | multiple sclerosis (is_implicated_in) | 2.15e-04 | 73 | 345 | 6 | DOID:2377 (is_implicated_in) | |
| Disease | lung adenocarcinoma | PDE3A ATP8B4 HLA-DPB1 HLA-DRB1 HLA-DRB3 DCBLD1 APOM PHLDB1 ACTR2 | 2.22e-04 | 174 | 345 | 9 | EFO_0000571 |
| Disease | Male sterility | 2.41e-04 | 48 | 345 | 5 | C0917731 | |
| Disease | Male infertility | 2.41e-04 | 48 | 345 | 5 | C0021364 | |
| Disease | Subfertility, Male | 2.41e-04 | 48 | 345 | 5 | C0848676 | |
| Disease | Subfertility, Female | 3.01e-04 | 28 | 345 | 4 | C0341869 | |
| Disease | Sterility, Postpartum | 3.01e-04 | 28 | 345 | 4 | C0038279 | |
| Disease | Female sterility | 3.01e-04 | 28 | 345 | 4 | C0917730 | |
| Disease | Female infertility | 3.01e-04 | 28 | 345 | 4 | C0021361 | |
| Disease | craniosynostosis (is_implicated_in) | 3.22e-04 | 12 | 345 | 3 | DOID:2340 (is_implicated_in) | |
| Disease | Liver Cirrhosis, Experimental | HIP1 INPP5D INPPL1 PSMB9 ADHFE1 FAT1 PLA2G12A ANGPTL3 SDS KNG1 FLNA TRPV1 RARRES1 NOX4 NFKBIZ NBEA SERPINA6 ECT2 MTMR7 GCAT UNC5CL | 3.49e-04 | 774 | 345 | 21 | C0023893 |
| Disease | intraocular pressure measurement | POU6F2 HLA-DRB1 HLA-DRB5 ADGRB2 ETS1 BBS9 ZNF469 HERC2 TTC41P MXRA8 NOX4 ZNF106 AFAP1 OR4C15 ADAMTS6 LTBP3 | 3.68e-04 | 509 | 345 | 16 | EFO_0004695 |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 4.06e-04 | 3 | 345 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | GLIOMA SUSCEPTIBILITY 1 | 4.06e-04 | 3 | 345 | 2 | 137800 | |
| Disease | hypoglycemia (biomarker_via_orthology) | 4.06e-04 | 3 | 345 | 2 | DOID:9993 (biomarker_via_orthology) | |
| Disease | Glioma susceptibility 1 | 4.06e-04 | 3 | 345 | 2 | cv:C2750850 | |
| Disease | Acrodermatitis | 4.06e-04 | 3 | 345 | 2 | C0001197 | |
| Disease | sputum mucin-5B amount | 4.06e-04 | 3 | 345 | 2 | OBA_2050332 | |
| Disease | acute disseminated encephalomyelitis (is_implicated_in) | 4.06e-04 | 3 | 345 | 2 | DOID:639 (is_implicated_in) | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 4.06e-04 | 3 | 345 | 2 | DOID:0080463 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 4.06e-04 | 3 | 345 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Aspirin-induced asthma | 4.06e-04 | 3 | 345 | 2 | HP_0012042 | |
| Disease | Anti-rubella virus IgG measurement | 4.06e-04 | 3 | 345 | 2 | EFO_0009357 | |
| Disease | Gianotti-Crosti Syndrome | 4.06e-04 | 3 | 345 | 2 | C0263372 | |
| Disease | Anti-hepatitis B virus surface antigen IgG measurement, response to vaccine | 4.06e-04 | 3 | 345 | 2 | EFO_0004645, EFO_0009358 | |
| Disease | Prescription Drug Abuse | 4.18e-04 | 115 | 345 | 7 | C4316881 | |
| Disease | Substance-Related Disorders | 4.18e-04 | 115 | 345 | 7 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.18e-04 | 115 | 345 | 7 | C0029231 | |
| Disease | Drug habituation | 4.18e-04 | 115 | 345 | 7 | C0013170 | |
| Disease | Drug abuse | 4.18e-04 | 115 | 345 | 7 | C0013146 | |
| Disease | Drug Use Disorders | 4.18e-04 | 115 | 345 | 7 | C0013222 | |
| Disease | Drug Dependence | 4.18e-04 | 115 | 345 | 7 | C1510472 | |
| Disease | Substance Dependence | 4.18e-04 | 115 | 345 | 7 | C0038580 | |
| Disease | Substance Use Disorders | 4.18e-04 | 115 | 345 | 7 | C0038586 | |
| Disease | Substance abuse problem | 4.41e-04 | 116 | 345 | 7 | C0740858 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.59e-04 | 153 | 345 | 8 | EFO_0004611, EFO_0020946 | |
| Disease | prostate cancer (is_implicated_in) | 4.64e-04 | 117 | 345 | 7 | DOID:10283 (is_implicated_in) | |
| Disease | apolipoprotein A 1 measurement | CPNE2 POU6F2 PDE3A PDE3B CEBPA HLA-DRB5 FCGR2B PLA2G12A LIPG ANGPTL3 ANKRD28 PRMT7 DOCK6 FNDC3A SIK3 THOC5 ZFPM2 WDR11 KANK4 MACF1 UBASH3B RNF111 | 4.64e-04 | 848 | 345 | 22 | EFO_0004614 |
| Disease | Ischemic stroke | PDE3A ATP8B4 TNFRSF21 PRDM8 LPCAT2 VIPR2 TRAPPC11 RNF17 TGFBR3 ZNF106 PCNX1 TNR | 4.77e-04 | 324 | 345 | 12 | HP_0002140 |
| Disease | calcium measurement | PDE3A ESR2 ZMYM2 SEMA3G ALKBH5 FBXO3 GNG12 KIF14 DMBT1 CASR SIK3 SERPINA6 ZFPM2 MTMR7 MACF1 CAMKMT UBASH3B AKAP1 | 4.85e-04 | 628 | 345 | 18 | EFO_0004838 |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 4.92e-04 | 85 | 345 | 6 | DOID:9744 (is_implicated_in) | |
| Disease | Glioma | 5.58e-04 | 87 | 345 | 6 | C0017638 | |
| Disease | Head and Neck Neoplasms | 5.75e-04 | 33 | 345 | 4 | C0018671 | |
| Disease | colorectal health | 6.37e-04 | 201 | 345 | 9 | EFO_0008460 | |
| Disease | chronic rhinosinusitis | 6.46e-04 | 34 | 345 | 4 | EFO_1000024 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | CPNE2 HLA-DRB1 PLA2G12A LIPG NPC1L1 DOCK6 SIK3 ZNF106 NANOS2 MACF1 HTT | 6.87e-04 | 291 | 345 | 11 | EFO_0008317, EFO_0020946 |
| Disease | vital capacity | POU6F2 HIC1 PDE3A AHI1 HLA-DRB1 ETS1 ITGB8 ADCY8 LRRIQ1 GNG12 AGER MAD1L1 KCNK2 BOP1 LTBP4 METAP2 AGAP1 ANKS1A HSPG2 ADAMTS1 WT1 AGPS ZNF106 LLGL2 ADAMTS6 GAB3 LTBP3 SAMD4A | 7.09e-04 | 1236 | 345 | 28 | EFO_0004312 |
| Disease | Urticaria | 7.92e-04 | 16 | 345 | 3 | C0042109 | |
| Disease | Acrocephaly | 7.92e-04 | 16 | 345 | 3 | C0030044 | |
| Disease | Trigonocephaly | 7.92e-04 | 16 | 345 | 3 | C0265535 | |
| Disease | Scaphycephaly | 7.92e-04 | 16 | 345 | 3 | C0265534 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 7.92e-04 | 16 | 345 | 3 | DOID:8947 (implicated_via_orthology) | |
| Disease | Synostotic Anterior Plagiocephaly | 7.92e-04 | 16 | 345 | 3 | C2931150 | |
| Disease | Synostotic Posterior Plagiocephaly | 7.92e-04 | 16 | 345 | 3 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 7.92e-04 | 16 | 345 | 3 | C4551902 | |
| Disease | Metopic synostosis | 7.92e-04 | 16 | 345 | 3 | C1860819 | |
| Disease | Gastrointestinal Neoplasms | 8.05e-04 | 4 | 345 | 2 | C0017185 | |
| Disease | anti-basement membrane glomerulonephritis (is_implicated_in) | 8.05e-04 | 4 | 345 | 2 | DOID:4780 (is_implicated_in) | |
| Disease | Malignant neoplasm of gastrointestinal tract | 8.05e-04 | 4 | 345 | 2 | C0685938 | |
| Disease | Thymus Neoplasms | 8.05e-04 | 4 | 345 | 2 | C3714644 | |
| Disease | Coughing | 8.05e-04 | 4 | 345 | 2 | C0010200 | |
| Disease | Allergic Reaction | 8.56e-04 | 63 | 345 | 5 | C1527304 | |
| Disease | Hypersensitivity | 9.20e-04 | 64 | 345 | 5 | C0020517 | |
| Disease | myocardial infarction | DCBLD1 ITGA1 TTC34 PLEKHG1 PRDM8 MAD1L1 DMBT1 LAMB2 ZFPM2 CSK HTT PHACTR1 | 9.35e-04 | 350 | 345 | 12 | EFO_0000612 |
| Disease | Inhalant adrenergic use measurement | 9.38e-04 | 96 | 345 | 6 | EFO_0009941 | |
| Disease | uric acid measurement | MYO9A PRDM8 ZNF276 NFATC1 SELENOO PLAAT2 UMOD ANKRD28 NSUN5P1 FRAS1 CDC42BPA CUBN AR FAF1 UNC5CL UBASH3B HERC4 | 9.39e-04 | 610 | 345 | 17 | EFO_0004761 |
| Disease | Brachycephaly | 9.54e-04 | 17 | 345 | 3 | C0221356 | |
| Disease | respiratory symptom change measurement, response to placebo | 9.54e-04 | 17 | 345 | 3 | EFO_0008344, EFO_0010068 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQELPYSLTSDNCEH | 101 | Q9NWW9 | |
| NCNGSLAHPSDLYAE | 181 | O60637 | |
| HSAALQVPCYAKESS | 146 | Q9H161 | |
| TTSLCESELHGKPNY | 311 | A9YTQ3 | |
| FPTCQALVYRGHSDL | 401 | Q14137 | |
| ELSYIINGTTDPHCA | 861 | O60241 | |
| IHGLPYSASTQDQRC | 731 | Q8N944 | |
| VRCLTGSEELYTIHP | 6 | P40145 | |
| EAVSEPHLGAYINAC | 471 | Q17RC7 | |
| LAVLDSSGRSSCYHP | 481 | Q7L0X2 | |
| SGICELHCPALVTYN | 261 | P04626 | |
| LHCPALVTYNTDTFE | 266 | P04626 | |
| TLDYSHCSLEQVPKE | 26 | Q96RT1 | |
| LPYTQSVQICHIEGS | 646 | Q92667 | |
| YQCPEHSQLTTLGVD | 21 | O95445 | |
| TSLPNGSSVIDHCYA | 746 | Q96N23 | |
| VDGIAQAYSACLPHI | 391 | Q96FN4 | |
| TLCDNGVLTYHPSLH | 371 | Q9UPQ3 | |
| TGYILDGHPQLTCIA | 206 | Q7Z407 | |
| TAPKTQYTGCSVHEN | 3656 | Q7Z407 | |
| ANYREKIHSTLTPCG | 841 | Q8N157 | |
| VSLGIDICHPDTFSY | 51 | Q9H568 | |
| VDSHSSLVGYCPQED | 2326 | Q86UK0 | |
| SIAHALQDIYTCLPG | 426 | P41180 | |
| LSGYAADEITHCIRP | 256 | Q6P6C2 | |
| GTALHYDDVPCINGS | 496 | Q8N556 | |
| YTCQTGQTSLSDPVH | 111 | P31994 | |
| CLSVLRSYQAEHGPD | 496 | O95870 | |
| TQCVKLAGATHYPLD | 306 | O96024 | |
| DLDERGCTPLHYAAT | 466 | O15084 | |
| PTISINKTDGCHAYL | 406 | Q01518 | |
| SCSLLHDGDPTYQRL | 611 | Q8IYT2 | |
| LLVCHVTDFYPGSIQ | 141 | P04440 | |
| DVYTCQVEHTSLDSP | 196 | P04440 | |
| GSALLPYHISSTACQ | 786 | Q9UKA4 | |
| PSCESVTDEYAGHLI | 1336 | Q9UKA4 | |
| QLVEHYTSDADGLCT | 151 | P41240 | |
| SELLDCGYHPESLLS | 16 | Q96D03 | |
| GITAIIHYCLLDPTT | 1726 | Q5JWR5 | |
| NVKHDGIPAECTTIY | 236 | Q9Y5C1 | |
| GIPAECTTIYNRGEH | 241 | Q9Y5C1 | |
| TNVADSKGCYPLHLA | 106 | Q92625 | |
| LSSSEPHGLCYVETA | 151 | Q8TF62 | |
| ISSGYQCTHVLPILE | 186 | Q9H9F9 | |
| CHALTTEDGTAYEPV | 571 | P78325 | |
| DGVTHICPVYEGFSL | 161 | P61160 | |
| ETLDYSGCLTHRPVE | 936 | Q9UKP5 | |
| VHCSSVPTGDQSLSY | 121 | Q8N0U7 | |
| LSSSEPHGLCYIETA | 171 | P98198 | |
| TASEVDCGDLQHLPY | 46 | O95803 | |
| LSNYHQLGTPGTESC | 266 | P18754 | |
| IGPQDQGTYSCVATH | 291 | Q15109 | |
| CELHPDLVSQTFGYL | 761 | Q5U651 | |
| VAEYIAPCSTDTEHG | 1466 | P20742 | |
| PVTSEHELTCQAEGY | 146 | Q9NZQ7 | |
| YICNATSPAGHAEAT | 3276 | P98160 | |
| EYGHIPSFLVDACTS | 61 | Q3KRB8 | |
| PETDLAHCFYSGTVN | 116 | Q9UHI8 | |
| YEVDGCPANLLSSHR | 656 | Q9H8V3 | |
| AYTHGCILHPELTTD | 156 | Q96MZ0 | |
| KYCLVAVPHGNDIAS | 351 | Q14573 | |
| YHIPSLSEALAQCEA | 476 | Q17RG1 | |
| TYLEQTGSNHRCPTL | 341 | Q9Y6F1 | |
| TDLTYPVHALGIITC | 161 | Q86VZ1 | |
| LDPSLCTHLIYAFAG | 46 | Q13231 | |
| SALYIGTHCEISVNP | 4041 | Q14517 | |
| IADHSYFCPVLATGL | 251 | Q8N612 | |
| LVSHAIPCYSLDGDN | 66 | O95340 | |
| FKETTATHCGVPNYL | 46 | Q9UHJ9 | |
| DSVIHLGCKPYLDSQ | 161 | Q9BZM1 | |
| YELHGSSPAVSSEEC | 1626 | Q15058 | |
| YPLLELACTDTHIFG | 181 | Q8NGM1 | |
| CHTGNSYPANAELSL | 731 | Q96JB6 | |
| QDALPEDHGTYTCLA | 571 | Q15746 | |
| PHHSEGACVYQDSLL | 21 | Q86XX4 | |
| EATNYDGLTPLHCAV | 546 | Q9BYH8 | |
| LTSLYAEHPGDCLIF | 651 | Q9Y6D9 | |
| EADPTGHSYVLVTCL | 161 | P43355 | |
| EVDPAGHSYILVTCL | 171 | P43361 | |
| PLCDIKGSYTAQFEH | 446 | P50579 | |
| SGEVYTCQVEHPSVT | 196 | Q30154 | |
| YNCSQSILPLEHGSI | 16 | Q92731 | |
| LPHSSCELLYLGTES | 136 | Q6P1M3 | |
| TDDGPYTCSVQTQHT | 111 | Q7Z3B1 | |
| LGSQISVCYVSSRPH | 1846 | Q4ZG55 | |
| EPAASGRIICHSYLE | 346 | Q9NQS7 | |
| AQVCSVASLLLDPHY | 346 | Q9Y216 | |
| SLPGHEDCGTILIVY | 496 | Q86UW9 | |
| EDCGTILIVYSIPHG | 501 | Q86UW9 | |
| GPEAAVNTHCAELYA | 206 | Q14526 | |
| SDTTVPLLNDCTEYH | 2871 | O95714 | |
| TCVVTYPENGRTFHL | 211 | Q9NPH3 | |
| PDYLVLSNCETGRLH | 181 | Q8WWW8 | |
| CHNVTPVYESRAGVT | 551 | O43861 | |
| SRVSCHSQADLQGPY | 756 | O43525 | |
| VSAAHCVYGRNLEPS | 821 | P98073 | |
| TSTQEPTEGLGECYH | 771 | Q8WW38 | |
| KTESIYLNGLTPHCA | 401 | O95069 | |
| LPSVLCYSDGTAVHE | 406 | Q8WYN3 | |
| ACLALGTTEYHPFTL | 1306 | Q9NRD8 | |
| TKRSSYLCESGPQAH | 461 | Q5CZC0 | |
| PVSVSCPELLDQHYT | 1136 | Q12766 | |
| CDLQSLLGYTPEELH | 416 | P14921 | |
| YTCQTGQTSLSDPVH | 111 | P31995 | |
| YVHDPECVATTGDIT | 271 | Q9UK99 | |
| HSCQSPEGRYSALKT | 631 | Q96RV3 | |
| AELSGNYTSAPHCLE | 1846 | Q9ULL4 | |
| NCSSVGSLSYIALPH | 741 | O60486 | |
| GTLPLTSIGNQHTYC | 636 | Q9NZN1 | |
| STVPHAYATADCDLG | 296 | O00330 | |
| QKPVTHCVEDGTYLA | 4856 | Q02817 | |
| CPNGGSLTHTYTHIE | 5136 | Q02817 | |
| YHSCVQLAPTRGLEE | 581 | Q76G19 | |
| SHIVGPLCNSYDSAG | 1006 | Q14432 | |
| FITHIVGPLCNSYDA | 991 | Q13370 | |
| HCADLSNPTKSLELY | 561 | Q07343 | |
| SPRLEYSGAITAHCS | 26 | A6NIU2 | |
| TAEIGASGSYCPQHV | 371 | Q7L5A3 | |
| EIIPDGYNDSLDTCH | 3846 | Q96JB1 | |
| IHLTGADQTTLLYCP | 746 | O94915 | |
| YTHGCILHPELTVDS | 136 | Q8TB36 | |
| EEYLPVSHTCFNLLD | 1016 | Q5GLZ8 | |
| DARVHTPSGAVEECY | 2441 | Q14315 | |
| DVYGILDCVSHTPAL | 186 | Q9H4Y5 | |
| ENHSYTLSLEPETGC | 621 | Q8TDF6 | |
| AAAVVGLLYPCIDSH | 136 | O15503 | |
| ESPRIEITSCLGLYH | 116 | O95644 | |
| HEGCYLSVGHSQPLE | 61 | Q9Y5X9 | |
| PLRIQSCYLGDHISD | 61 | A0A1B0GTW7 | |
| RYQCHEEGLVPSKTS | 746 | P55268 | |
| VEIEALTPHSSYCVV | 226 | Q969J5 | |
| PSYHDLVFQCGSDST | 171 | Q8N5I3 | |
| DGLSCPRSIILEYHQ | 4971 | P98088 | |
| HTLFTAEEGQLYGPC | 436 | P10275 | |
| TVSHIEGYECQPIFL | 661 | P10275 | |
| CANNYLGLSSHPEVI | 71 | O75600 | |
| EPPEVGSDCTTIHYN | 221 | P04637 | |
| NVSDGCHIYTFIEIP | 231 | A6NLU0 | |
| REVHYVLLDPSCSGS | 31 | Q3KNT7 | |
| SSYEEAHKALCILPG | 231 | O15527 | |
| PLHERIYCALSGSAA | 56 | P28065 | |
| TDTEHNPCGAIVTGY | 846 | Q9P2E7 | |
| LHYTTGICSDVSPTF | 141 | P56199 | |
| GRVYHSTPSDLCVVD | 356 | Q0VG06 | |
| GDRVTYTINPSSHCN | 4086 | Q7Z6Z7 | |
| DTICEINYSAIHPGL | 611 | P16144 | |
| CIYSPEGHVLTLDAL | 151 | Q27J81 | |
| YSSHQLKTPDGVVVC | 76 | P60321 | |
| DGHLQCSYLGTDPSL | 351 | Q3SYG4 | |
| HAPCEGLSNYNAESS | 681 | Q96JM4 | |
| PAVSHLDSGDYICQA | 316 | Q9P2V4 | |
| KSLGQVSLTHPYSEC | 2881 | Q9UPN3 | |
| IHCAGYSDPILVQTL | 1206 | O75694 | |
| GQYITLHCPSVSALE | 336 | Q9NPH5 | |
| SCITYQPLVSGEHKA | 426 | A2A3N6 | |
| CIISTGDSHTFDPYN | 286 | Q7Z442 | |
| EALYSVPGEHCLTLQ | 196 | Q86VF5 | |
| VSEDTCPLNVHSYDP | 916 | Q86Y26 | |
| EQRVPCSTSYHSSGL | 331 | Q9C0D0 | |
| PSLRLFGDHDYCQSI | 376 | Q9UBK2 | |
| TTYLDLQTCHVFSLP | 501 | Q7L5N7 | |
| LSPRLEYSGTISAHC | 1051 | Q9UHC9 | |
| SKGCSVDSIEYPSVH | 91 | P26012 | |
| YDGPSSNSHLLTQLC | 1226 | O60494 | |
| PNAYDSLTHCSSLLE | 2706 | O60494 | |
| HYETTGPALCTIVFL | 306 | Q13467 | |
| SGEVYTCQVEHPSVT | 196 | P79483 | |
| GAVTIQCHYAPSSVN | 76 | Q8WWV6 | |
| YTHVDDCSLNEPGST | 1181 | Q9ULT8 | |
| SEESTPSIIYHCALR | 2866 | P42858 | |
| DEGLYTCSFQTRHQP | 106 | A6NGN9 | |
| YRCTAQNPLGSTDTH | 411 | Q96ID5 | |
| DAGIYECHTPSTDTR | 121 | Q969P0 | |
| PCQSHASYSLLEEED | 306 | Q9NWV8 | |
| DVLVVDPGTRCHYST | 166 | A8MY62 | |
| PELGHVYTCLVDHSS | 191 | P13765 | |
| SLLCGHDTDPRYAEA | 1141 | Q96HP0 | |
| AEQEYSLPCTAEHGF | 66 | Q9Y603 | |
| SYCEEHARSDPLLIG | 41 | Q9UBI6 | |
| LPVDHKGELLCSYSN | 351 | Q9Y6W3 | |
| EYHLTPECTLSTGLL | 616 | Q9NVM4 | |
| CTLHETPYILSTGDS | 901 | Q03188 | |
| YSKPSISGIESDDHC | 2041 | O15078 | |
| SIRCPESGEHYEVTL | 841 | Q86TI2 | |
| AKVHSPSGALEECYV | 2366 | P21333 | |
| CEHETSIDISAYIDP | 56 | P49715 | |
| EIENPHYSPSTCLAI | 866 | Q9Y2H6 | |
| GQISAGYSPVIDCHT | 351 | Q05639 | |
| GQISAGYAPVLDCHT | 351 | P68104 | |
| NLPYDVTSPALCDTH | 271 | Q9H9V9 | |
| QAGLTCDYSELPHHI | 356 | Q49AR2 | |
| VHPGDVLITSCTYNT | 456 | P09172 | |
| LACLITGYHPTSVTV | 26 | P01880 | |
| AHSSSPCLVTGYTDA | 211 | Q8IX06 | |
| CSVSQPAINYLLSHG | 156 | Q58HT5 | |
| YCDRLVQDTPFLTGH | 6 | Q96LW7 | |
| HTVYCQDGSPSVGLS | 46 | P28067 | |
| SGEVYTCQVEHPSVT | 196 | P01911 | |
| VCSAIHNPTGRSYTI | 621 | O14744 | |
| DSLSGTEIPLHYICK | 151 | O75072 | |
| VYSSAEFHSLCPDGK | 961 | Q9NS15 | |
| LTPELGGTLQYCHSE | 76 | P10911 | |
| TETAEYQSLCPHGRG | 1226 | Q8N2S1 | |
| VDTESALLYQGPHNT | 36 | P13612 | |
| NCLEHGYPELASAIK | 576 | Q5T7N3 | |
| VQSIPHPCYNSSDVE | 101 | O60259 | |
| IHSYPEGICLSQASK | 276 | Q9BZJ6 | |
| VTAQYDCLGCVHPIS | 136 | P01042 | |
| CGDVLYLPTSSQDHT | 36 | Q6PEX3 | |
| CEISYSPLQSDEDTH | 296 | Q6PJP8 | |
| VTLNPHALVVCGTYS | 866 | Q6PJP8 | |
| LAESGLSYPCHRLTV | 251 | Q9UNN5 | |
| PLFYSEVEETCLSHT | 166 | Q8NDH2 | |
| VEAEFPYGQLSTSCH | 421 | Q9H4B8 | |
| DRYVDCPATGHNLSV | 411 | Q49AJ0 | |
| GCQVSPEGYAHLTHL | 751 | Q9UBN7 | |
| TYASSDHPDLITCLE | 146 | Q8N8Z6 | |
| SPCHFTLVTGKYIEN | 76 | Q6UWV6 | |
| LYLSEKENVGPSCHL | 1126 | Q9C0D2 | |
| TSLDGHAYLCLPRSQ | 126 | Q96MH7 | |
| GSSPHGVRLVDNYCE | 1326 | P39059 | |
| PIVLDDVRCSGHESY | 1441 | Q9UGM3 | |
| VEPACGAALAAVYSH | 266 | P20132 | |
| RYNSHLVPEDGTLTC | 341 | O76054 | |
| LISPTHISDAGTYTC | 461 | Q58EX2 | |
| SVYHITDVPCIFSGD | 196 | Q9NZJ4 | |
| ATQLGAYCPFLIESH | 1796 | Q6ZTR5 | |
| QSSTISYLHDSELPC | 236 | P08185 | |
| GESRLQHSPSQSYLC | 686 | P80192 | |
| ICSHISVNQDSGPEY | 11 | A6NMZ7 | |
| ENSCPVGAHIAILSY | 1791 | A6NMZ7 | |
| IGELDQSHFTCYAPV | 351 | Q9NT99 | |
| LLEHGEEYTFSLPCA | 556 | Q9BXB4 | |
| FDVLCHALESYTTLP | 241 | Q8IWW8 | |
| GSCAAHAYKQVDPSI | 56 | Q9Y316 | |
| QYESLPATHIRGKCS | 96 | Q9BTC8 | |
| ESPSNCRHLEALDGY | 151 | Q11128 | |
| HYKCSTPSTDATVQG | 116 | Q9P2B2 | |
| EYCLGPTHEEAITAL | 151 | Q7L3T8 | |
| EYGHIPSFLVDACTS | 61 | Q6P4F7 | |
| ACHPDTVEGVYRALS | 1636 | Q9C093 | |
| HLLRVAYQDPSSGCT | 626 | Q13671 | |
| SPVSFENEHSYLCTV | 371 | P19320 | |
| EISDLHYLSPSGCTF | 321 | Q6ZMZ0 | |
| LPALTHDGRYTCTAA | 226 | Q6ZMC9 | |
| TQLHYCESTGIPLVV | 451 | P49590 | |
| SLHYEEITKGPNCVI | 871 | A6NHR9 | |
| YATLTPVDCLAFAGH | 321 | O75151 | |
| TPLHVAASCGYLDIA | 136 | Q9BZL4 | |
| PAGTYVSEHCTNTSL | 71 | O75509 | |
| QLTEACPYLGTHSEE | 656 | A2VDJ0 | |
| HDVSQSYQPCEGTFL | 331 | P0C2Y1 | |
| YTCTGHPLKSDIANI | 236 | P40937 | |
| DYPVVLSLENHCSTA | 241 | Q86YW0 | |
| SQIGDDRPISYCHFS | 226 | O43172 | |
| PQITTNHSGLYACSV | 381 | Q00889 | |
| HTPGSRLQCTYIEVE | 51 | Q96FV2 | |
| RGHTACADAYLTPAI | 231 | O14841 | |
| ATEGPAYSQSAICRH | 511 | P78424 | |
| SYLTDKGCNPTHLAD | 281 | Q05397 | |
| PRLISVSSEGHCIIY | 2826 | Q8NFP9 | |
| FGPCVLSHTSLYDSI | 41 | Q9NQV8 | |
| PCYHTLGLEVIGSEQ | 606 | Q9BRB3 | |
| SQYLACPEDISGLLH | 676 | O00291 | |
| DITGLLEHYKDPSAC | 356 | Q8WXH5 | |
| TAKNSISVLDYPHCV | 626 | Q5VSL9 | |
| PLVHVVCQSYGSTSD | 681 | Q92835 | |
| KLLETPYHCEAGAAT | 621 | Q9BVL4 | |
| SYGCTDDIVTSDHSP | 706 | O15357 | |
| SHSYDCTVDLLEFQP | 81 | Q6ZNX1 | |
| PDLSDGSQHLNSSCY | 1281 | Q9Y2K2 | |
| LYSDHSPLCADSLGQ | 431 | Q13796 | |
| YTETGLSPDSHCLDI | 11 | Q6ZUB0 | |
| LDSASHDCPLVTQTY | 386 | Q9Y4P8 | |
| HDCPLVTQTYGAAAG | 391 | Q9Y4P8 | |
| TVSSGTKEHCYNQVP | 1081 | Q14191 | |
| ISYSPGVCSIEHQQE | 671 | Q5VT25 | |
| LDVNVRSSCGYTPLH | 661 | A6NEL2 | |
| GTTQCQRTEHPVISY | 26 | Q13591 | |
| QLATIFTHCYGSSPI | 806 | Q8N961 | |
| TIHNITPGDAGEYVC | 336 | Q8IZF2 | |
| TCVLYTPSNEHFGIV | 316 | Q9H553 | |
| YCTGHEPDSLEFSTV | 296 | O00116 | |
| CPEYSISLRHNSGSL | 96 | Q7Z624 | |
| AGCALEPSYVEALHS | 136 | Q8IVV8 | |
| SVTVCHINSPGDFYL | 681 | Q9BXT8 | |
| GPTVYQLLSACSHFE | 81 | P11086 | |
| DYLKDPVTISCGHNF | 21 | Q5EBN2 | |
| EINLAATHEPTYQGS | 521 | Q32MQ0 | |
| YTETGLSPDSHCLDI | 11 | P0C874 | |
| ILLSVEYSCHGVPTI | 51 | A8MXK1 | |
| SNLVSVGYCAHKPEV | 46 | Q06732 | |
| ASVGLNVPASVCYSH | 66 | P47985 | |
| VYQSTEILHCLGPDN | 61 | P63129 | |
| HVTLHGTELCDESYP | 806 | Q7Z392 | |
| TLANIHLAYAPTSCS | 301 | P60852 | |
| ECHLAYCTDPSSVEG | 281 | P07911 | |
| GTSYHEQQALPVDLS | 556 | Q6ZNA4 | |
| GPVHSSLYDLSCIDT | 376 | Q8NER1 | |
| PYITQDICSGHDIHA | 181 | Q6T4P5 | |
| INTCGGISSPYHEEL | 11 | C9JQI7 | |
| VYQSTEILHCLGPDN | 61 | P63121 | |
| HRELLGVCSDPYTLA | 191 | Q8N431 | |
| GVCSDPYTLAQQLTH | 196 | Q8N431 | |
| LTSDGRTIVCYHPSV | 51 | Q9Y6G3 | |
| VYAVHNSCPGLSEAT | 131 | Q96A56 | |
| ANITLPHGALTECYD | 96 | Q8WUN7 | |
| APPLSSSTIHYECVD | 116 | Q6ZN55 | |
| QPHSGLLQSGVISCY | 256 | Q86VE9 | |
| DYLSDPVTIECGHNF | 21 | A6NK02 | |
| VYQSTEILHCLGPDN | 61 | P63131 | |
| YEEGDQLKILPCSHT | 316 | Q8WWF5 | |
| QESAATGQLDYIPHC | 161 | Q92752 | |
| IDYTISFHGIVCTAP | 746 | P29144 | |
| SHFSLYTCVLEAPVG | 226 | Q8IV45 | |
| GALPHLQRTLSSEYC | 211 | Q8N554 | |
| VYQSTEILHCLGPDN | 61 | Q9Y6I0 | |
| VYQSTEILHCLGPDN | 61 | P63125 | |
| YESDNHTTPILCGAQ | 271 | P19544 | |
| LLIPHFVGSTCESSY | 366 | Q6P2S7 | |
| TCHSVGAAYLESLPL | 471 | P28908 | |
| SIIEHLSVVFPCYNS | 1846 | P53804 | |
| GLADPHSLCYDITVI | 26 | Q6H3X3 | |
| TVALPDELSYICTHG | 2641 | Q709C8 | |
| VGLANACYAIHTLPT | 1916 | P08922 | |
| LADYLHTNPIETSGA | 441 | O94813 | |
| FLHYDCGNKTVTPVS | 61 | Q5VY80 | |
| HIYNGTRPCELISSN | 186 | O00507 | |
| APEHCYIENLRGTLT | 81 | Q86UU1 | |
| TRHPCSLGSSLVADY | 376 | P13994 | |
| LPGTFLNHTEDEYEC | 521 | Q8TE23 | |
| ICSEAFSLVSHLNPY | 186 | Q9BZ71 | |
| TYALKCDSSGHAPEI | 1016 | Q9BYW2 | |
| VCLATGFYPDHVELS | 166 | P0DTU4 | |
| VTGLHCVGDTYPSND | 26 | P43489 | |
| DVLYSSSGTLHCPDQ | 181 | P41587 | |
| ASYAASPSHCLSVEG | 2641 | Q96JG9 | |
| QSCVSEYKQVGSHPS | 496 | Q9UBW7 | |
| EQSCEYETRLPGNHS | 31 | Q9UNY5 | |
| ECGSLYNTLEEVLSH | 61 | Q8TF50 | |
| EGECHPVSVASTAYN | 286 | Q8N3G9 | |
| SENCHLPGIATSYFV | 1571 | Q9UI33 | |
| VYGTEHNSTFLECLP | 591 | Q9NS98 | |
| ATLVCLATGFYPDHV | 26 | A0A5B9 | |
| SVGLNVPASVCYSHT | 76 | P0C7P4 | |
| NPGIHLCSVGSYTIN | 561 | Q7Z2W4 | |
| HSTYSNGELADFCLP | 1086 | Q9ULL1 | |
| SYAHPLECSSVLEES | 861 | Q13395 | |
| LLESNTIIDHVYCSP | 456 | Q8TF42 | |
| LSQIGFPHCEDYVAS | 56 | Q502W6 | |
| LEHGIVPVTSDCQYL | 496 | Q13769 | |
| GRADPHSLCYDITVI | 26 | Q9BZM5 | |
| FLHYDCGNKTVTPVS | 61 | Q9BZM5 | |
| HNIGSPYCLRLASAD | 76 | Q9BZH6 | |
| SEYESGSACPAQTVH | 351 | Q9HAU0 | |
| GSDSAVLYLHVTCPL | 876 | Q8WY21 | |
| PAHIESEGSGVCQLY | 1296 | A3KMH1 | |
| GVLAQEISHYSFCPL | 1161 | Q9P2L0 | |
| VHPSDTGTYLCQVNN | 111 | Q96IQ7 | |
| YHCQELQTPEEASGT | 266 | P49788 | |
| CGKPFTESSYLTQHL | 246 | Q9BR84 | |
| IHDVAPEDSGRYTCI | 651 | Q13308 | |
| SDDCTIVAYGNLHPQ | 311 | Q9BVG3 | |
| YSHCRALLSQLPDTG | 266 | A8MYJ7 | |
| VVLSISPNCGYINSH | 771 | Q04912 | |
| EDNHGPYISKLRSSC | 496 | Q9H2Y7 | |
| GCENGHVPLYSSSSV | 211 | Q9UPU9 | |
| VYQSTEILHCLGPDN | 61 | P63119 | |
| PEVGYCRDLSHITAL | 181 | P35125 | |
| SHYTIIENICPKDES | 651 | Q03167 | |
| RHSLGEDCIYPQSSE | 331 | Q9ULM3 | |
| KLSVYLTDHTGDIPC | 321 | Q9Y473 | |
| LSRNPESGYIEVEHC | 281 | Q9H977 | |
| VYQSTEILHCLGPDN | 61 | P63124 | |
| SYGELLHCLSEEPEI | 426 | P07101 | |
| VYQSTEILHCLGPDN | 61 | P63120 | |
| RDHYLASGNTSVAPC | 86 | P23276 | |
| QLLCPEHSEGAAYLE | 211 | O14686 | |
| PLEVADEGTYSCHLH | 261 | Q9BRK3 | |
| YHCSGKDQIVPSLNT | 1466 | B2RTY4 |